UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

(Mark One)

☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended June 30, ~~2022~~2023

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission File Number: 000-54853

SMARTMETRIC, INC.

(Exact name of registrant as specified in its charter)

Nevada		05-0543557
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		identification No.)

3960 Howard Hughes Parkway, Suite 500, Las Vegas, NV		89109
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (702) 990-3687

Securities registered under Section 12(b) of the Exchange Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
N/A		N/A		N/A

Securities registered pursuant to section 12(g) of the Act:

Common Stock, par value $0.001 per share

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐ Yes ☒ No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transaction period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes ☒ No

~~The~~If ~~aggregate~~securities ~~market~~are ~~value~~registered ofpursuant ~~the voting and non-voting common equity held by non-affiliates was $8,331,803 computed by reference~~ to ~~the~~Section ~~closing~~12(b) ~~price~~ of the ~~registrant’s~~Act, ~~common~~indicate ~~stock as quoted on the OTCQB maintained~~ by ~~OTC~~check ~~Markets,~~mark ~~Inc.~~whether ~~on December 31, 2020 (~~the ~~last~~financial ~~business~~statements ~~day~~ of the registrant~~’s most recently completed second fiscal quarter) (which was $0.02 per share).~~ ~~For~~included ~~purposes~~in of the ~~above~~filing ~~statement~~reflect ~~only,~~the ~~all~~correction ~~directors,~~of ~~executive~~an ~~officers~~error ~~and 10% shareholders are assumed~~ to bepreviously ~~affiliates. This~~issued ~~determination~~financial ~~of affiliate status is not necessarily a conclusive determination for any other purpose~~statements. ☐

As The aggregate market value of ~~October 13,~~the ~~2022,~~voting ~~there~~and ~~were~~non-voting ~~472~~common equity held by non-affiliates was $2,~~859~~159,~~208~~324 ~~shares~~computed by reference to the closing price of the registrant’s common stock as quoted on the OTCQB maintained by OTC Markets, ~~par~~Inc. ~~value~~on June 30, 2023 (the last business day of the registrant’s most recently completed second fiscal quarter) (which was $0.001 ~~issued~~per share). For purposes of the above statement only, all directors, executive officers and ~~outstanding~~10% shareholders are assumed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for any other purpose.

As of June 30, 2023, there were 2,222,951,485 shares of common stock, par value $0.001 issued and outstanding.

TABLE OF CONTENTS

			~~Page~~	Page
	~~PART I~~	PART I
Item 1.	~~BUSINESS~~	BUSINESS	1	1
Item 1A	~~RISK FACTORS~~	RISK FACTORS	9	9
Item 1B	~~UNRESOLVED STAFF COMMENTS~~	UNRESOLVED STAFF COMMENTS	17	18
Item 2.	~~PROPERTIES~~	PROPERTIES	18	19
Item 3.	~~LEGAL PROCEEDINGS~~	LEGAL PROCEEDINGS	18	19
Item 4.	~~MINE SAFETY DISCLOSURES~~	MINE SAFETY DISCLOSURES	18	19
	~~PART II~~	PART II
Item 5.	~~MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS ISSUER PURCHASES OF EQUITY SECURITIES~~	MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS ISSUER PURCHASES OF EQUITY SECURITIES	19	20
Item 6	~~SELECTED FINANCIAL DATA~~	SELECTED FINANCIAL DATA	21	22
Item 7.	~~MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS~~	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	21	22
Item 7A	~~QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK~~	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	25	26
Item 8.	~~FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA~~	FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA	25	26
Item 9.	~~CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE~~	CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE		27
Item 9A.	~~CONTROLS AND PROCEDURES~~	CONTROLS AND PROCEDURES	26	27
Item 9B.	~~OTHER INFORMATION~~	OTHER INFORMATION	27	28
	~~PART III~~	PART III
Item 10.	~~DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE~~	DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE	28	29
Item 11.	~~EXECUTIVE COMPENSATION~~	EXECUTIVE COMPENSATION	30	32
Item 12.	~~SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS~~	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS	32	34
Item 13.	~~CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE~~	CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE	33	35
Item 14.	~~PRINCIPAL ACCOUNTING FEES AND SERVICES~~	PRINCIPAL ACCOUNTING FEES AND SERVICES	34	36
	~~PART IV~~	PART IV
Item 15.	~~EXHIBITS, FINANCIAL STATEMENT SCHEDULES~~	EXHIBITS, FINANCIAL STATEMENT SCHEDULES	35	37

FORWARD LOOKING STATEMENTS

In this annual report, references to “SmartMetric, Inc.,” “SmartMetric,” “SMME,” “the Company,” “we,” “us” and “our” refers to SmartMetric, Inc. Also, any reference to “common shares,” or “common stock” refers to our $0.001 par value common stock. Also, any reference to “preferred stock” or “preferred shares” refers to our $0.001 par value Series B Convertible Preferred Stock and our $0.001 par value Series C Convertible Preferred Stock.

This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to our business development plans, timing strategies, expectations, anticipated expense levels, business prospects, business outlook, technology spending and various other matters (including contingent liabilities and obligations and changes in accounting policies, standards , and interpretations). These statements express our current intentions, beliefs, expectations, strategies, or predictions as well as historical information. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will,” “could,” “continue,” and similar expressions or variations of such words are intended to identify forward-looking statements, but are not deemed to represent an all-inclusive means of identifying forward-looking statements as denoted in this Annual Report on Form 10-K. Additionally, statements concerning future matters are forward-looking statements.

Although forward-looking statements in this Annual Report on Form 10-K reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. These statements are not a guarantee of future performance and involve risks and uncertainties that are difficult to predict. Our future operating results are dependent upon many factors which are outside our control. You should not place undue reliance on forward-looking statements. Forward-looking statements may not be realized due to a variety of factors, including, without limitation, our ability to:

●

manage our business given continuing operating losses and negative cash flows;

●

obtain sufficient capital to fund our operations, development, and expansion plans;

●

manage competitive factors and developments beyond our control;

●

maintain and protect our intellectual property;

●

obtain patents based on our current and/or future patent applications;

●

obtain and maintain other rights to technology required or desirable to conduct or expand our business; and

●

manage any other factors discussed in the “Risk Factors” section, and elsewhere in this annual report.

We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Annual Report on Form 10-K, except as required by federal securities laws. Readers are urged to carefully review and consider the various disclosures made throughout the entirety of this Annual Report, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

PART I

Item 1.

Business

Corporate History and Overview

SmartMetric, Inc. (“SmartMetric” or the “Company”) is a company that was incorporated pursuant to the laws of Nevada on December 18, 2002 and is focused on the biometric technology manufacturing industry. SmartMetric has an issued patent covering technology that involves connection to networks using data cards (smart cards and EMV cards). In addition, SmartMetric holds the sole license to five issued patents covering features of its biometric fingerprint activated cards. SmartMetric’s main products are fingerprint sensor activated payments card for use in the credit and debit card industry, which are currently under development. The SmartMetric fingerprint biometric cards being developed by the Company have a rechargeable battery allowing for portable biometric identification and card activation prior to being presented to or inserted in, a credit or debit card reader. These cards are herein sometimes referred to as a biometric card or the SmartMetric Biometric Card.

The Market for Biometric Credit Cards

Estimated Market Size

The estimated size of the market for biometric credit and debit cards is significant. While the company is not making any projections on the actual size of the market a number of industry figures point to the outsized market size and potential.

According to EMVCo, which is a credit card standards body responsible for the licensing and rules governing EMV chips used on today’s credit and debit cards, more than 10 billion EMV chip cards have been issued by banks globally.

SmartMetric contracted an independent consumer market research company to ascertain the potential consumer demand for a credit card with incorporated fingerprint biometrics. The survey was conducted in the USA and the respondents were Visa credit card users.

The result of the consumer research survey is as follows.

1: Are you concerned about credit card or identity fraud?

Answered Yes: 80.1%

2: Would you pay for a safer biometric secured credit card that has a built-in fingerprint reader for your protection?

Answered Yes: 65.5%

3: What would you prefer to pay for a biometric fingerprint secured safer credit card?

Answer 1: $69.95 onetime charge for the life of the card (3 years) 60.2%

Answer 2: $8.95 per month (includes identity theft insurance) 39.7%

Given these consumer research results and given the number of credit cards issued by banks, it is a large potential market that SmartMetric is developing its product for.

All credit and debit cards that are to be issued by a Bank must be tested and approved of by the card brand network that the card is to operate on. Visa, MasterCard, American Express and Diners brands and networks all have their own individual testing and approval procedures. The card brand that SmartMetric is working with published its biometric testing procedures in March of 2021. This caused SmartMetric to make changes to its card design, adding its newly invented anti-spoofing live fingerprint detection technology to its biometric card.

The SmartMetric Biometric Technology and Products

SmartMetric’s founder, Chaya Hendrick, is the originator and inventor of various miniature biometric activated cards, including the SmartMetric biometric fingerprint activated payments card with an embedded fully functional fingerprint reader inside the card, which is currently in development. The design of the card is the size and thickness of a standard credit card. The SmartMetric biometric payments card should provide high level security for credit and debit cards by adding biometric authentication and activation to Europay, MasterCard and Visa (“EMV”) chip cards in use around the world. The SmartMetric biometric payments card will be engineered to be inoperable with existing EMV chip card readers, ATMs as well as banking payments infrastructure. Using the advanced electronic miniaturization by SmartMetric to make its biometric credit/debit cards, the Company is also in development of a multi-functional biometric building access control and logical network access card.

SmartMetric has commenced efforts towards creating a biometric health insurance card with memory for storing a person’s medical files, including medical images. This should allow a person to securely take with them their private medical files inside the card when traveling away from home. For the first time, a person’s complete medical files would be stored in a credit card-sized card and the information is only able to be accessed by the card holder’s own fingerprint.

SmartMetric is developing its rechargeable battery powered fingerprint reader that is of a scale that fits “inside” a standard credit or debit card. The cardholder would then have stored inside the card his or her fingerprint. To activate the card, the person would swipe the fingerprint sensor, the sensor would connect to an internal microprocessor that manages the fingerprint sensor, fingerprint image capture and comparison matching with the pre-stored fingerprint of the cardholder held in the internal electronic memory of the card. The card is being designed to have a surface mounted EMV chip as found on EMV banking chip cards that is activated or turned on only after a card holder’s fingerprint has been scanned and verified using the SmartMetric miniature “in-card” biometric scanner. It is important to note that as of the date of this filing, no prototype yet exists.

There are over ten (10) billion EMV chip cards used by banks around the world for credit cards, ATM cards and debit cards according to EMVco. SmartMetric sees this existing user base as a natural market for its advanced biometric activated card technology for the credit and debit card market. SmartMetric has established a network of card manufacturers and technology distributors to market its in-card biometric products to card issuing banks and in the case of the SmartMetric biometric security card, to businesses, once fully developed.

SmartMetric is also developing a multi-function logical and physical access security card the size and thickness of a standard credit card. Utilizing the small size breakthroughs by the Company in its biometric payments card development, SmartMetric is now developing a biometric security card that is the size and thickness of a standard credit card that can easily fit inside a person’s wallet.

As with the biometric payments card, the SmartMetric security card will have an internal rechargeable battery that is used to power the card’s internal processor used in the biometric fingerprint scan. All functions and operations of the card are subject to a valid fingerprint scan and match of the card user.

Additional technological advances have now been made with regard to both the Company’s biometric credit/debit card and its multifunction cyber security, building access biometric card, both of which are still under development and have not yet been produced.

In Card Fingerprint Matching and Verification

The SmartMetric Biometric card will incorporate a rechargeable, lithium polymer battery. This battery should be rechargeable and very thin, and it has been designed by SmartMetric to fit inside the SmartMetric fingerprint credit card sized card. This battery is planned to be manufactured by a third party unaffiliated with the Company to SmartMetric’s specifications. This battery is planned to be embedded inside the card.

Other components needed for manufacture of the SmartMetric Biometric Card include, but are not limited to, sensors, microchips, memory chips and processor chips. The ultra-thin circuit board developed by SmartMetric has, in total, nearly 200 active and passive components. The sources and availability of these materials are numerous, and readily available in SmartMetric’s view, and should not affect the ability of SmartMetric to meet future demand. However, the supply of memory processors and passive components may be interrupted at any time based on global supply/demand issues. We are still in our design and development phase and have not experienced component supply issues to date, and we plan, as a matter of policy, to alternative component sources to mitigate and protect against future potential supply chain issues.

The biometric card is being designed to offer the option of a built-in radio frequency transmitter for contactless access and identity verification. The RFID contactless chip transmission would then be turned on using the card users fingerprint verification.

The thinness form factor of many of the planned components has also resulted in the Company having to develop its own process for high volume electronic assembly. The Company believes that it has also successfully overcome the challenge of developing a process of encapsulating the electronics in plastic to create the credit card sized biometric fingerprint activated card that also has an internal rechargeable battery.

Standard credit card manufacturing utilizes machines that require high pressure and high temperature in fusing top and bottom sheets of plastic together thereby encasing any electronics inside the card. Given the complexity of the card’s electronics and vulnerability to an assembly process involving high heat and high pressure, damage to the electronic circuitry in our planned biometric card is a major challenge for the Company to overcome. Research and development activities of the Company have allowed the Company to develop a production plan and process that addresses this challenge, and this trade secret process should protect the silicon and internal battery that will be mounted directly onto the card’s internal electronics circuit board.

The Security Technology Industry

SmartMetric Biometric Multi-Function Security Card

SmartMetric is developing a multi-function logical and physical access security card the size and thickness of a standard credit card. Utilizing the small size breakthroughs by the Company in its biometric payments card development, SmartMetric is developing a biometric security card that can easily fit inside a person’s wallet.

The main features of the SmartMetric biometric security card are:

Logical access smartcard card chip for insertion into a card reader attached to a computer or network

2. RFID transceiver for physical access i.e., doorways, elevators, etc.

Validation indicator light that glows green immediately following a fingerprint validation

Rechargeable battery to power the card

Size and thickness of a credit card

Changeable security code on reverse of card for additional log on security

Cybersecurity and identity validation for network access control, physical building entry and secure on-the-spot identity security is now handled by the revolutionary biometric activated cyber and ID multi-function security card which has been in development by SmartMetric.

From governments to the workplace, better, stronger security is desired across the enterprise. Our new biometric multifunction security card should provide a revolutionary biometric based solution that is portable, easily integrated and backward compatible to existing backend security infrastructure.

The new multifunction biometric security card by SmartMetric is engineered to provide a large leap forward in the Cyber and Access Security world according to SmartMetric.

Access management market is estimated to grow from USD 8.09 billion in 2016 to USD 14.82 billion by 2021, at a CAGR of 12.9% between 2016 and 2021 according to a recent research report by KBV Research in a publication titled Identity & Access Management Market – Global Forecast by Marqual IT Solutions Pvt. Ltd (KBV Research) November 2016 KBV Research is a name owned by IT Solutions Pvt. Ltd.

The new multifunction biometric security card by SmartMetric is engineered to provide a large leap forward in the Cyber and Access Security world according to SmartMetric.

Access management market is estimated to grow from USD 8.09 billion in 2016 to USD 14.82 billion by 2024, at a CAGR of 12.9% between 2016 and 2024 according to a recent research report by KBV Research in a publication titled Identity & Access Management Market – Global Forecast by Marqual IT Solutions Pvt. Ltd (KBV Research) November 2016 KBV Research is a name owned by IT Solutions Pvt. Ltd.

Biometrics

Biometric technologies identify users by electronically capturing a specific biological or behavioral characteristic of that individual, such as a fingerprint or voice or facial feature, and creating a unique digital identifier from that characteristic. Because this process relies on largely unalterable human characteristics, positive identification can be achieved independent of any information possessed by the individual seeking authorization.

The process of identity authentication typically requires that a person present for comparison with one or more of the following factors:

● Something known such as a password, PIN, or mother’s maiden name;

●

Something carried such as a token, card, or key; or

●

something physical such as fingerprint, voice pattern, signature motion, facial shape or other biological or behavioral characteristic.

Comparison of biological and behavioral characteristics has historically been the most reliable and accurate of the three factors but has also been the most difficult and costly to implement into a single product that can automatically verify the identity of a user accessing a computer network or the Internet. However, recent advances in biometric collection technologies (both biometric hardware products and their associated processing software) have increased the speed and accuracy and reduced the cost of implementing biometrics in commercial environments. Management believes that individuals, website operators, government organizations, and businesses will increasingly use this method of identity authentication.

Biometrics refers to the automatic identification of a person based on his/her physiological or behavioral characteristics. This method of identification is preferred over traditional methods involving passwords and personal identification numbers (“PINs”) for two reasons: (i) the person to be identified is required to be physically present at the point of identification to be identification; and (ii) identification based on biometric techniques obviates the need to remember a password or carry a token. By replacing PINs, biometric techniques can potentially prevent unauthorized access to or fraudulent use of cellular phones, Biometric cards, desktop PCs, workstations, and computer networks. It can be used during transactions conducted via telephone and Internet (e-commerce and e-banking). In automobiles, biometrics could replace keys-less entry devices. The SmartMetric fingerprint activated credit card that has the fingerprint encased inside the credit card has been developed to replace the less secure PIN’s for credit and debit cards.

PINs and passwords may be forgotten, may be hacked and token-based methods of identification, e.g., passports and driver’s licenses, may be forged, stolen or lost. Various types of biometric systems are being used for real-time identification, with the most popular based on facial recognition and fingerprint matching. Other biometric systems utilize iris and retinal scanning, speech, facial thermograms and hand geometry. Of the biometric options available to work with a credit or debit card, fingerprint scanning is the only biometric methodology that has been successfully reduced in size to fit inside such cards.

A biometric system is essentially a pattern recognition system, which makes a personal identification by determining the authenticity of a specific physiological or behavioral characteristic possessed by the user. An important issue in designing a practical system is to determine how an individual is identified.

There are two different ways to resolve a person’s identity; verification and identification. Verification (Am I whom I claim I am?) involves confirming or denying a person’s claimed identity. In identification, one has to establish a person’s identity (Who am I?).

As stated above, the SmartMetric fingerprint biometric card has been designed as a credit-card sized card embedded with an integrated circuit, contact chip and biometric fingerprint sensor. The SmartMetric card has been designed to provide not only memory capacity, but also computational capability along with secure non-refutable identification of the user. We believe that the self-containment of SmartMetric’s card makes it substantially resistant to attack, as it will not need to depend upon vulnerable external resources. Because of this characteristic, we expect that the SmartMetric biometric card may be used in different applications, which require strong security protection and authentication.

The physical structure of a card is specified by the International Standards Organization (“ISO”). Generally, this structure is made up of three elements: (i) the plastic card, which is the most basic one and has the dimensions of 85.60mm x 53.98 x 0.80mm; (ii) an electronic circuit board inlay; and (iii) a contact chip that are embedded in the card.

The SmartMetric card has been designed to conform to ISO standards. The electronic circuit inlay is a part of, and not distinct from, the biometric card.

The communication line between the card and ATMs and other standard Smart Card reading devices is bi-directional serial transmission, which conforms to ISO standards. Card commands and input data are sent to the chip that responds with status words and output data upon the receipt of these commands and data. Information is sent in half duplex mode (transmission of data is in one direction at a time). This protocol, together with the restriction of the bit rate, is designed to prevent data attack on the card. Other data protection systems are utilized inside the card including advanced encryption.

In general, the size, the thickness and bend requirements for the biometric card were designed to protect the card from being spoiled physically.

Recent Developments

SmartMetric has presented its fingerprint activated biometric card to a large global payments network and credit/debit card brand. The company has been advised that the card testing and approval requirements for this network is that the company’s biometric fingerprint scanning must be able to differentiate between a live finger and a fake finger at the time of fingerprint scanning. This is to protect the card from what is called in the industry, spoofing.

The adopted method for this kind of anti-spoofing detection within the biometric industry is performed through intelligent software analysis done at the time of the fingerprint scan. SmartMetric has tested this methodology and was not confident in its robustness in performing the task at hand. So as to ensure a high level of anti-spoofing capability, SmartMetric has developed its own method that it believes exceeds the normal standard within the biometric industry.

SmartMetric is in development of its advanced live finger detection method and is now working on its incorporation into the company’s biometric card. Once this has been completed, the company will then be presenting its card for testing as a biometric card to the global payments network. SmartMetric has received a license from this network to move forward with its product testing by the networks designated biometric card test laboratory.

The company’s product is being engineered differently from most other biometric cards that have been announced in that it has its own internal rechargeable battery. This is important and a must if the card is to be used at ATM’s.

Other differentiations are the now newly developed advanced anti-spoofing technology.

Various versions of the SmartMetric fingerprint biometric card are under development including but not limited to a version that has one time password OTP display and another that has a small display for showing the cards CVV.

Other cards under development based on the company’s biometric technology include memory cards with up to 2GB of memory. Also cards that have much larger display screens that can display such things as Q-Codes.

The large-scale memory fingerprint biometric protected card has potential application in the portable medical records industry as well as advanced applications in the banking and financial transaction industries.

Years of research and development has gone into the miniaturization of the electronics at the core of the SmartMetric fingerprint biometric card. All of the design and electronic engineering has been undertaken by SmartMetric and is the owned property and trade secrets of the company.

The card being developed by SmartMetric has its own ARM Cortex processor along with additional memory. The user’s fingerprint is stored inside the cards memory and is protected by advanced very strong elliptic curve cryptography.

5Equity Financing Agreement

~~GHS~~ On March 5, 2020, the Company entered into an equity financing agreement (the “Equity Financing Agreement”) ~~and~~with ~~Registration~~GHS ~~Rights~~Investments, LLC, a Nevada limited liability company (“GHS”). Pursuant to the Equity Financing Agreement, the Company agreed to sell to GHS an indeterminate amount of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), up to an aggregate price of four million dollars ($4,000,000).

~~On March 6,~~Following ~~2020~~effectiveness of the Registration Statement, the Company ~~entered~~shall ~~into~~have anthe ~~equity~~discretion ~~financing~~to ~~agreement~~deliver (puts to GHS and GHS will be obligated to purchase shares of the ~~“Equity~~Company’s ~~Financing~~Common ~~Agreement”),~~Stock ~~and a~~based ~~registration~~on ~~rights~~the ~~agreement~~investment (amount specified in each put notice. The maximum amount that the ~~“Registration~~Company ~~Rights~~shall ~~Agreement”)~~be ~~with~~entitled to put to GHS ~~Investments~~in ~~LLC,~~each aput ~~Nevada~~notice ~~limited~~shall ~~liability company~~not exceed two hundred percent (~~“GHS”~~200%). ~~Under~~of the ~~terms~~average daily trading dollar volume of the Company’s Common Stock during the ten (10) trading days preceding the put, so long as such dollar amount does not exceed $500,000. Pursuant to the Equity Financing Agreement, GHS ~~agreed~~and its affiliates will not be permitted to ~~provide~~purchase and the Company ~~with~~may upnot toput ~~$4,000,000 over~~shares of the ~~course~~Company’s ofCommon 36Stock ~~months~~to GHS that would result in ~~return~~GHS’s ~~for~~beneficial ~~shares~~ownership, equaling more than 4.99% of the Company’s ~~common~~outstanding ~~stock~~Common Stock. The ~~36-month~~price ~~period~~of ~~will~~each ~~commence~~put ~~upon effectiveness~~share ofshall abe ~~registration~~equal ~~statement~~to oneighty ~~Form~~percent ~~S-1~~(80%) of the Market Price (as defined in the ~~“Registration~~Equity ~~Statement”~~Financing Agreement). ~~filed~~Puts ~~with~~may be delivered by the ~~U.S.~~Company ~~Securities and~~to ~~Exchange~~GHS ~~Commission~~until (the ~~“Commission”~~earlier of thirty-six (36) onmonths ~~August 6,~~after ~~2020~~the effectiveness of the Registration Statement.

~~Following effectiveness~~Concurrently ofwith the ~~Registration~~execution ~~Statement,~~of the ~~Company~~Equity ~~shall~~Financing ~~have~~Agreement, the ~~discretion~~Company toentered ~~deliver~~into ~~puts~~a toconvertible ~~GHS~~promissory ~~and~~note, ~~GHS~~for ~~will~~the beprincipal ~~obligated to~~balance ~~purchase shares~~ of ~~the Company’s common stock, par value~~ $035,000.~~001~~ ~~per~~Per ~~share (~~the ~~“Common~~terms ~~Stock”)~~of ~~based on~~ the ~~investment~~ ~~amount~~convertible ~~specified~~promissory innote, ~~each put notice. The maximum amount that~~ the Company ~~shall~~agreed ~~be entitled~~ to ~~put~~pay to GHS ininterest ~~each~~at ~~put notice~~the ~~shall~~rate ~~not~~of ~~exceed~~ten ~~two hundred~~ percent (~~200~~10%) ofuntil ~~the~~it ~~average~~became ~~daily~~due ~~trading~~on ~~dollar~~December 5, ~~volume~~2020. ofThe ~~the~~holder ~~Company’s~~of ~~Common Stock during~~ the ~~ten~~convertible ~~(10)~~promissory ~~trading~~note ~~days~~shall ~~preceding~~have the ~~put,~~right soat ~~long~~any astime ~~such~~to ~~amount~~convert ~~does~~all ~~not~~or ~~exceed~~any ~~$500,000.~~part ~~Pursuant~~of to the ~~Equity~~outstanding ~~Financing Agreement, GHS~~ and ~~its~~unpaid ~~affiliates~~principal ~~will not be permitted to purchase,~~ and ~~the~~interest ~~Company~~at ~~may~~a ~~not~~fixed ~~put~~conversion ~~shares~~price of ~~the Company’s Common Stock to GHS that would result in GHS’s beneficial ownership equaling more than 4~~$0.~~99% of the Company’s outstanding Common Stock~~0175. The ~~price~~principal balance of ~~each~~$35,000 ~~put~~was ~~share~~been ~~shall~~recognized beas ~~equal~~deferred tofinancing ~~eighty~~costs ~~percent (80%) of the Market Price (as defined~~ in ~~the~~current ~~Equity Financing~~assets ~~Agreement). Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the Registration Statement, the date~~ on ~~which GHS has purchased an aggregate of $4,000,000 worth of Common Stock under~~ the ~~terms~~ ofaccompanying ~~the~~Consolidated ~~Equity~~Balance ~~Financing Agreement~~Sheet, orand atwas ~~such~~charged ~~time~~against ~~that~~ the ~~Registration~~gross ~~Statement~~proceeds isof noeach ~~longer~~put inwhen ~~effect~~received. ~~Additionally, in~~The ~~accordance~~note ~~with~~was ~~the~~paid ~~Equity Financing Agreement, the Company issued GHS a convertible promissory note~~ in ~~the~~full ~~principal~~on ~~amount of $35~~July 14,~~000~~ ~~and a 9 month maturity date (the “Commitment Note”)~~2022, ~~with~~as ~~the~~indicated ~~first~~in ~~$20,000 of~~ the ~~Commitment~~subsequent ~~Note~~events ~~deemed earned~~in ~~upon execution of~~ the ~~Equity~~previously ~~Financing~~filed ~~Agreement and the remaining $15~~June 30,~~000~~ of2022 ~~the~~form ~~Commitment Note deemed earned upon payment by GHS of the Company’s legal fees~~10-K.

The Registration Rights Agreement provides that the Company shall (i) use its best efforts to file with the Commission the Registration Statement within 60 days of the date of the Registration Rights Agreement; and (ii) have the Registration Statement declared effective by the Commission within 30 days after the date the Registration Statement is filed with the Commission, but in no event more than 90 days after the Registration Statement is filed.

On July 14, 2022, the Company paid the note in full. See subsequent events.

Sales and Marketing

SmartMetric has engaged distributors and dealers in both North and South America. SmartMetric has entered into an agreement with RedSys the owner of the ADVANTIS credit and debit card chip that is used in over 1.4 Billion credit/debit cards globally. RedSys/Advantis is owned by card issuing Banks. Five hundred (500) card issuing banking organizations around the world are issuing credit and debit cards with the RedSys/ADVANTIS chip.

SmartMetric has added the ADVANTIS credit/debit card chip onto the SmartMetric biometric card thereby allowing the existing RedSys / ADVANTIS banks already issuing credit and debit cards with their chip on board to now issue seamlessly the SmartMetric biometric credit/debit card. RedSys/ ADVANTIS have agreed to work closely with SmartMetric in promoting the SmartMetric card globally. RedSys/ADVANTIS is owned by some of the largest Banks in Europe and Latin America.

Manufacturing

The Company designs and develops its biometric technology. Current production capacity is approximately 250,000 cards per week that can be substantially increased over a relatively short period of time.

A picture containing indoor, floor, ceiling, standing

Description automatically generated

SmartMetric’s President & CEO in the card lamination factory.

Intellectual Property

We rely on patents, licenses, trade secrets, trademarks, copyright registrations and non-disclosure agreements to establish and protect our proprietary rights in our technologies and products. A number of patents are in process (Patents Pending) that cover critical aspects of the engineering and function of the SmartMetric biometric card. The founder of SmartMetric, Chaya Hendrick, is the inventor of these patents, and has provided SmartMetric with an option over biometric card related pending patents invented by her.

Some of the most recent Patents Pending have not been disclosed on the publicly searchable USPTO database of filed for patents and remain trade secrets within the Company. Publishing of such Patents Pending will be done in due course.

Patents

SmartMetric biometric card is protected by five (5) USPTO issued patents. Other patents are pending. Our technology is also dependent upon unpatented trade secrets. However, trade secrets are difficult to protect. In an effort to protect our trade secrets, we have a policy of requiring our employees, consultants and advisors to execute non-disclosure agreements. The principal shareholder of SmartMetric and technology inventor, Chaya Hendrick, through various corporate investment vehicles and companies also owns other technologies, patents, and has financial interest in other technology companies. Chaya Hendrick, under an executed employment agreement is not subject to any restriction on using and owning any technology, methodology, process or invention created by Chaya Hendrick.

Government Regulation

There are currently no governmental regulations, which have any bearing on the raw materials or the manufacturing of our payments card products. United States federal departments such as the Department of Defense have rules and regulations concerning security features of smart cards used as identity or building and cyber access cards. These regulations stipulate a specific licensing and testing protocol for such cards.

Banking Industry Self-Regulation

The EMV chip used in chip cards are subject to licensing and testing by the banking-controlled body called EMVco. EMVco is an acronym standing for Europay, MasterCard and Visa. These international payments card networks were the founding parties of EMVco.

Individual payments networks such as Visa, Mastercard, Europay, American Express, Union Pay Dinners and JCB all have their own individual licensing and testing standards and processes.

Research and Development

Our research and development program is focused on ongoing development of new products built on our existing biometric card. We continue to refine our technology and develop further improvements to our biometric card products. We have finalized our first biometric EMV payments card product. We have also concluded the design and electronic engineering for our soon-to-be released multi-function security and access control biometric cards. Research and development will continue as the Company continues to innovate and develop new biometric card-based products. Future biometric card-based products the Company is now working on, include but are not limited to: (a) health insurance card with stored in-card medical records; (b) national identity card; and (c) drivers’ licenses.

The Company has developed and is continuing to develop its own embedded systems and application software that works with the SmartMetric Biometric Card. This development software and systems and ongoing electronic design and development requires the company to continue to expend time and financial resources on significant software development. Currently, the Company has electronic and software engineers working in Tel Aviv, Israel and Buenos Aires, Argentina.

Competition

Various potential competitors have announced products similar to that of SmartMetric’s. It is understood that “announced” is defined as a person to hold their finger on the cards fingerprint sensor while it is in a card reader. Unlike the SmartMetric biometric card that is powered from its own internal rechargeable battery, this other type of card does not allow the card to be used in most restaurants that need to take the card away from the table for processing at the checkout. It also does not allow their other type of card to be used at the vast majority of ATM’s.

Employees

As of the date of this annual report, we have one full time employee, our Chief Executive Officer and President, Chaya Hendrick. We primarily use direct contract hires in administration and engineering, as is common in the information technology world. All work product developed by all of our engineers remains the intellectual property of SmartMetric. Engineers who work for SmartMetric under contract are primarily based in Tel Aviv, Israel. Some software engineering is conducted in Buenos Aires, Argentina.

Corporate History

We were incorporated in the State of Nevada on December 18, 2002 and our principal office is located in Las Vegas, Nevada. Since our inception, we have invested a substantial portion of our efforts and financial resources in the development of our products. We have generated no revenues from the sale of our products and have experienced substantial net operating losses.

We entered into a royalty and licensing agreement with Chaya Hendrick, our CEO, which requires substantial payments by us on an annual basis and additionally in the event gross revenues are derived, which could harm our financial position.

Pursuant to a licensing and royalty agreement, entered into on September 11, 2017 by the Company and Chaya Hendrick, our founder and CEO, we received a license to certain patents related to our technologies until the expiration of such patents in exchange for the following: (i) issuance of 200,000 Series B Convertible Preferred Shares, (ii) 5% of gross revenues derived from the sale of products derived from the patents, and (iii) annual payments beginning at $50,000 per annum, increased by 100% of each previous year (offset against 5% gross revenue royalty payments). We believe these patents are instrumental our business plan and if we are unable to make such required payments under the license agreement, Chaya Hendrick may terminate the agreement, which may materially impact our business plan. As of June 30, ~~2022~~2023, we had issued the 200,000 shares of Series B Convertible Preferred Stock as required by the license agreement, and Ms. Hendrick had waived the right to annual payments through June 30, ~~2022~~2023. There can be no assurances that we will be able to continue to meet our financial obligations under the terms of the agreement unless we are able to raise additional capital through the sale of our securities or derive revenue from some other source.

Where to Find More Information

We make our public filings with the SEC, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all exhibits and amendments to these reports. These materials are available on the Company’s website at www.smartmetric.com or on the SEC’s web site, http://www.sec.gov.

Item 1A.

Risk Factors

The Company, as a smaller reporting company (as defined by Rule 12b-2 of the Exchange Act), is not required to furnish information required by this item. However, the following important factors among others, could cause our actual operating results to differ materially from those indicated or suggested by forward-looking statements made in this Annual Report or presented elsewhere by management from time to time. We have described below a number of uncertainties and risks which, in addition to uncertainties and risks presented elsewhere in this Annual Report, may adversely affect our business, operating results and financial condition. The uncertainties and risks enumerated below as well as those presented elsewhere in this Annual Report should be considered carefully in evaluating us, our business and the value of our securities.

Risks Related to Our Financial Position and Need to Raise Additional Capital

We have a limited operating history as a company and may not be able to effectively operate our business.

Our limited staff and operating history mean that there is a high degree of uncertainty regarding our ability to:

●

develop our technologies and proposed products;

● identify, hire, and retain the needed personnel to implement our business plan and sell our products;

●

Manage our growth and / or successfully scale our business; or

●

respond to competition.

No assurances can be given as to exactly when, if at all, we will be able to fully develop, and take the necessary steps to derive any revenues from our proposed products.

Our business depends upon our ability to keep pace with the latest technological changes, and our failure to do so could make us less competitive in our industry.

The market for our services is characterized by rapid change and technological improvements. Failure to respond in a timely and cost-effective way to these technological developments may result in serious harm to our business and operating results. As a result, our success will depend, in part, on our ability to develop and market service offerings that respond in a timely manner to the technological advances of available to our customers, evolving industry standards and changing preferences.

Raising capital may be difficult as a result of our history of losses and limited operating history in our current stage of development.

When making investment decisions, investors typically look at a company’s management, earnings, and historical performance in evaluating the risks and operations of the business and the business’s future prospects. Our history of losses and relatively limited operating history in our current stage of development makes such evaluation, as well as any estimation of our future performance, substantially more difficult. As a result, investors may be unwilling to invest in us or on terms or conditions which are acceptable. If we are unable to secure additional financing, we may need to materially scale back our business plan and/or operations or cease operations altogether.

We are an early-stage company, have no product revenues, are not profitable and may never be profitable.

From inception through June 30, ~~2022~~2023, we have raised approximately $2829,000,000 through the sale of our securities. During this same period, we have recorded an accumulated deficit of approximately $30(31,~~496~~431,~~042~~438). Our net losses available to common shareholders for the two most recent fiscal years ended June 30, ~~2022~~2023 and ~~2021~~2022 were $1935,~~687,438~~396 and $~~924~~1,~~728~~636,678, respectively. We have never made any sales and have never generated revenues and we anticipate none will be generated for the foreseeable future. We expect to incur significant operating losses for the foreseeable future as we continue the development of our products. Accordingly, we will need additional capital to fund our continuing operations and any expansion plans. Since we do not generate any revenue, the most likely source of such additional capital is the sale of our securities. To the extent that we raise additional capital by issuing equity securities, our stockholders are likely to experience dilution with regard to their percentage ownership of the company, which may be significant. If we raise additional capital by incurring debt, we could incur significant interest expense and become subject to covenants that could affect the manner in which we conduct our business, including securing such debt obligations with our assets.

To date, we have generated only losses, which are expected to continue for the foreseeable future.

For the years ended June 30, ~~2022~~2023 and ~~2021~~2022, we incurred a net loss of $1935,~~687,438~~396 and $~~924~~1,~~728~~636,678, respectively. We may not be able to achieve expected results, including any guidance or outlook it may provide from time to time.

We may continue to incur losses and may be unable to achieve profitability. We cannot assure you that our net losses and negative cash flow will not accelerate and surpass our expectations, nor can we assure you that we will ever generate any net income or positive cash flow.

We may not be able to continue as a going concern if we do not obtain additional financing by December 31, ~~2022~~2023.

Since our inception, we have funded our operations primarily through the sale of our securities. Our cash and cash equivalents balance at June 30, ~~2022~~2023 was $~~126~~20,~~791~~012. Based on our current expected level of operating expenditures, we expect to only be able to fund our operations through the second quarter (ending December 31, ~~2022~~2023) of our fiscal year ending June 30, 2023, at which time we will need additional capital. Our ability to continue as a going concern is wholly dependent upon obtaining sufficient capital to fund our operations. We have no committed sources of additional capital and our access to capital funding is always uncertain. Accordingly, despite our ability to secure capital in the past, we cannot assure you that we will be able to secure additional capital through financing transactions, including issuance of debt, or through other means. In the event that we are not able to secure additional funding, we may be forced to curtail operations, delay, or stop ongoing clinical trials, cease operations altogether or file for bankruptcy.

If we are unable to continue as a going concern, our securities will have little or no value.

Although our financial statements have been prepared under the assumption that we would continue our operations as a going concern, there is substantial doubt about our ability to continue as a going concern, based on our financial statements and results of operations at that time. Specifically, as noted above, we have experienced losses from operations and negative cash flows from operating activities due primarily to relatively high general and administrative expenses associated with launching our business and also due our Company not yet entering the card manufacturing phase.~~_____.~~

Although our audited financial statements for the years ended June 30, ~~2022~~2023 and ~~2021~~2022, were prepared under the assumption that we would continue our operations as a going concern, the report of our independent registered public accounting firm that accompanies our financial statements for the years ended June 30, ~~2022~~2023 and ~~2021~~2022, contains a going concern qualification in which such firm expressed substantial doubt about our ability to continue as a going concern, based on our financial statements and results at that time, including sustaining recurring losses and having an accumulated deficit as of June 30, ~~2022~~2023.

We expect to continue to incur significant expenses and operating losses for the foreseeable future. These prior losses and expected future losses have had, and will continue to have, an adverse effect on our financial condition. In addition, as noted above, continued operations and our ability to continue as a going concern will likely be dependent on our ability to obtain additional financing in the near future and thereafter, and there are no assurances that such financing will be available to us at all or will be available in sufficient amounts or on reasonable terms. Our financial statements do not include any adjustments that may result from the outcome of this uncertainty. If we are unable to generate additional funds in the future through sales of our products, financings or from other sources or transactions, we will exhaust our resources and will be unable to continue operations. If we cannot continue as a going concern, our shareholders would likely lose most or all of their investment in us.

Pursuant to a licensing and royalty agreement, entered into on September 11, 2017 by the Company and Chaya Hendrick, our founder and CEO, we received a license to certain patents related to our technologies until the expiration of such patents in exchange for the following: (i) issuance of 200,000 Series B Convertible Preferred Shares, (ii) 5% of gross revenues derived from the sale of products derived from the patents, and (iii) annual payments beginning at $50,000 per annum, increased by 100% of each previous year (offset against 5% gross revenue royalty payments). We believe these patents are instrumental our business plan and if we are unable to make such required payments under the plan, Chaya Hendrick may terminate the agreement, which may materially impact our business plan. As of June 30, ~~2022~~2023, we had issued the 200,000 shares of Series B Convertible Preferred Stock as required by the license agreement, and Ms. Hendrick had waived the right to annual payments through June 30, ~~2022~~2023. There can be no assurances that we will be able to continue to meet our financial obligations under the terms of the agreement unless we are able to raise additional capital through the sale of our securities or derive revenue from some other source.

As of June 30, ~~2022~~2023, the Company owes Chaya Hendrick, our CEO, $~~753~~769,~~475~~309 in deferred officer salary, of which the failure to pay could result in Chaya Hendrick’s termination of employment, the result of which would materially harm our business.

We currently have not paid $~~753~~769,~~475~~309 in salary owed to Chaya Hendrick pursuant to Chaya Hendrick’s employment agreement outstanding with us as of June 30, ~~2022~~2023. While Chaya Hendrick continues to support the Company and continues to operate as its CEO, President and chairman of the Board of Directors, there can be no assurances that this will continue if we fail to pay back salaries and future salary owed. Additionally, as of July 1, 2017, all prior and future deferred salary owed will bear interest at a rate of 7% per annum. In the event Chaya Hendrick terminates employment for lack of payment, the Company believes such loss would cause irreparable harm to our product development and would materially harm our business prospects. Additionally, there can be no assurances that Chaya would not attempt to foreclose on our assets in order to satisfy such debt obligations.

Risks Relating to our Stage of Development and Business

Our potential competitors have significantly greater resources than we have, which may make competing difficult.

We compete against numerous companies, many of which have substantially greater resources than we have. Several such competitors have large teams of engineers and scientists that attempt to develop products and technologies similar to ours. Companies such as Gemalto, Giesecke & Devrient, IDEMIA, as well as others, have substantially greater financial, research, manufacturing , and marketing resources than we do. As a result, such competitors may find it easier to compete in our industry and bring competing products to market.

Our business depends upon our ability to keep pace with the latest technological changes, and our failure to do so could make us less competitive in our industry.

Our key personnel and directors are critical to our business, and such key personnel may not remain with our company in the future.

We depend on the continued employment of our President and CEO, Chaya Henrick, and technical contracted personnel. If any of these key personnel were to leave and not be replaced with sufficiently qualified and experienced personnel, our business could be adversely affected. In particular, our current strategy to penetrate the market for contactless logical access identification and transaction solutions is heavily dependent on the vision, leadership and experience of our President and CEO, Chaya Hendrick.

Our continued success will depend, to a significant extent, upon the performance and contributions of Chaya Henrick and upon our ability to attract motivate and retain highly qualified management personnel and employees. We depend on Chaya Henrick to effectively manage our business in a highly competitive environment. If one or more of our key officers join a competitor or form a competing company, we may experience interruptions in product development, delays in bringing products to market, difficulties in our relationships with customers and loss of additional personnel, which could significantly harm our business, financial condition, operating results , and projected growth.

We currently ~~employ~~contract aaccountant ~~part-time~~and Chief Financial Officer, Mr. Jay Needelman, who is also a member of the Company’s Board of Directors. The loss of services of any of our key management personnel, whether through resignation or other causes, the reduced services of our part-time Chief Financial Officer, or the inability to attract qualified personnel as needed, could prevent us from adequately executing our business strategy.

Rapid technological changes could make our services or products less attractive.

The smart card, biometric identification and personal identification industries are characterized by rapid technological change, frequent new product innovations, changes in customer requirements and expectations and evolving industry standards. If we are unable to keep pace with these changes, our business may be harmed. Products using new technologies, or emerging industry standards, could make our technologies less attractive. If addition, we may face unforeseen problems when developing our products, which could harm our business. Furthermore, our competitors may have access to technologies not available to us, which may enable them to produce products of greater interest to consumers or at a more competitive cost.

Sales of our products depend on the development of emerging applications in their target markets and on diversifying and expanding our customer base in new markets and geographic regions, all of which may be financially burdensome or unsuccessful.

Our intent is to market and sell our products primarily to the private sector while addressing emerging applications that have not yet reached a stage of mass adoption or deployment. The market for some of these solutions (electronic biometric fingerprinting) is at an early stage of deployment in the private sector compared to other forms of services that try to identify a person through simpler means (by their name, social security number, etc.) Additionally, we have a strategy of expanding sales of existing products into new geographic markets. Our target market initially will be South America and Australia. In the event that we are unable to adequately develop our applications or gain traction in these emerging markets, or that the cost of the foregoing is too great, our business may be harmed.

Continuing disruption in the global financial markets may adversely impact customers and customer spending patterns.

Continuing disruption in the global financial markets as a result of the ongoing global financial uncertainty may cause consumers, businesses , and governments to defer purchases in response to tighter credit, decreased cash availability and declining consumer confidence. Accordingly, demand for our products could decrease and differ materially from their current expectations. Further, some of our customers may require substantial financing in order to fund their operations and make purchases from us. The inability of these customers to obtain sufficient credit to finance purchases of our products and meet their payment obligations to us or possible insolvencies of our customers could result in decreased customer demand, an impaired ability for us to collect on outstanding accounts receivable, significant delays in accounts receivable payments, and significant write-offs of accounts receivable, each of which could adversely impact our financial results.

Risks Related to Our Intellectual Property

If we are not able to adequately protect our intellectual property, we may not be able to compete effectively.

Our ability to compete depends in part upon the strength of our proprietary rights in our technologies, brands and content. The efforts we have taken to protect our intellectual property and proprietary rights may not be sufficient or effective at stopping unauthorized use of our intellectual property and proprietary rights. In addition, effective trademark, patent, copyright, and trade secret protection may not be available or cost-effective in every country in which our products are made available. There may be instances where we are not able to fully protect or utilize our intellectual property in a manner that maximizes competitive advantage. If we are unable to protect our intellectual property and proprietary rights from unauthorized use, the value of our products may be reduced, which could negatively impact our business. Our inability to obtain appropriate protections for our intellectual property may also allow competitors to enter our markets and produce or sell the same or similar products. In addition, protecting our intellectual property and other proprietary rights is expensive and diverts critical managerial resources. If any of the foregoing were to occur, or if we are otherwise unable to protect our intellectual property and proprietary rights, our business and financial results could be adversely affected. If we are forced to resort to legal proceedings to enforce our intellectual property rights, the proceedings could be burdensome and expensive. In addition, our proprietary rights could be at risk if we are unsuccessful in, or cannot afford to pursue, those proceedings.

We may incur substantial costs as a result of litigation or other proceedings relating to patent and other intellectual property rights and we may be unable to protect our rights to, or use of, our technology.

Some or all of our patent applications may not issue as patents, or the claims of any issued patents may not afford meaningful protection for our technologies or products. In addition, patents issued to us or our licensors, if any, may be challenged and subsequently narrowed, invalidated, or circumvented. Patent litigation is widespread in our industry and could harm our business. Litigation might be necessary to protect our patent position or to determine the scope and validity of third-party proprietary rights. If we choose to go to court to stop someone else from using the inventions claimed in our patents, that individual or company would have the right to ask the court to rule that such patents are invalid and/or should not be enforced against that third party. These lawsuits are costly and we may not have the required resources to pursue such litigation or to protect our patent rights. In addition, there is a risk that the court might decide that these patents are not valid and that we do not have the right to stop the other party from using the inventions. There is also the risk that, even if the validity of these patents is upheld, the court could refuse to stop the other party on the grounds that such other party’s activities do not infringe on our rights contained in these patents.

Furthermore, a third party may claim that we are using inventions covered by their patent rights and may go to court to stop us from engaging in our normal operations and activities, including making or selling our product candidates. These lawsuits are costly and could materially increase our operating expenses and divert the attention of managerial and technical personnel. There is a risk that a court would decide that we are infringing the third party’s patents and would order us to stop the activities covered by the patents. In addition, there is a risk that a court would order us to pay the other party damages for having violated the other party’s patents. It is not always clear to industry participants, including us, which patents cover various types of products or methods of use. The coverage of patents is subject to interpretation by the courts, and the interpretation is not always uniform.

Because some patent applications in the United States may be maintained in secrecy until the patents are issued, patent applications in the United States and many foreign jurisdictions are typically not published until eighteen months after filing, and publications in the scientific literature often lag behind actual discoveries, we cannot be certain that others have not filed patent applications for technology covered by our issued patents or that we were the first to invent the technology. Our competitors may have filed, and may in the future file, patent applications covering technology similar to ours. Any such patent application may have priority over our patent applications and could further require us to obtain rights to issued patents covering such technologies.

If another party has filed a United States patent application on inventions similar to ours, we may have to participate in an interference or other proceeding in the U.S. Patent and Trademark Office, or the PTO, or a court to determine priority of invention in the United States. The costs of these proceedings could be substantial, and it is possible that such efforts would be unsuccessful, resulting in a loss of our United States patent position with respect to such inventions.

Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the capital necessary to continue our operations.

Risks Relating to Market Approval and Government Regulations

Compliance with regulation of corporate governance and public disclosure diverts time and attention away from revenue generating activities.

Our management team invests significant time and financial resources to comply with existing standards for public companies, which has led to management time and attention from developing our business to compliance activities which could have an adverse effect on our business.

Our technology relies on our ability to gain the acceptance and approval of large banking / credit card institutions, the failure to do so may materially harm our business.

In the event that our SmartMetric Biometric Card does not gain acceptance/approval amongst the large card issuing institutions in the United States and abroad, our cards will not be provided for use to customers. We currently have no plans to open our own bank/credit card issuing institution and accordingly, we plan to rely on our ability to have our products accepted within the banking/credit card industries. Our failure to do so will have a material impact on our ability to generate revenues and continue to operate our business.

Risks Relating to the Development and Manufacturing of Our Products

We currently rely on third party manufacturers and suppliers for certain components of our product; with such parties being, to some extent, outside of our control.

We currently have limited internal manufacturing capability and intend to rely on third party contract manufacturers or suppliers for the foreseeable future. Accordingly, factors outside of our control may result in material manufacturing delays and product shortages, which could delay or otherwise negatively impact our manufacturing and product development plans. Should we be forced to manufacture our proposed products, we cannot give any assurance that we would be able to develop internal manufacturing capabilities. In the event that we seek third party suppliers or alternative manufacturers, they may require us to purchase a minimum amount of materials or could require other unfavorable terms. Any such event could materially impact our business prospects and could delay the development and manufacturing of our products. Moreover, we cannot give any assurance that the contract manufacturers or suppliers that we select will be able to supply our products in a timely or cost-effective manner or in accordance with our specifications.

We have a limited number of suppliers of key components and may experience difficulties in obtaining components for which there is significant demand, which would materially impact our business prospects.

We rely upon a limited number of suppliers for some key components of our products. Our reliance on a limited number of suppliers may expose us to various risks including, without limitation, an inadequate supply of components, price increases, late deliveries , and poor component quality. In addition, some of the basic components we use in our products, such as biometric fingerprint devices and various smart card technologies may at any time be in great demand. This could result in components not being available to us in a timely manner or at all, particularly if larger companies have ordered more significant volumes of those components, or in higher prices being charged for components. Disruption or termination of the supply of components or software used in our products could delay shipments of these products. The following delays/factors from our third-party suppliers could have a material adverse effect on our business and operating results and could also damage relationships with current and prospective customers:

●

Difficulties in staffing;

●

Adequate resources of qualified technicians, engineers/assemblers, and programmers;

●

Potentially adverse tax consequences;

● Unexpected changes in regulatory requirements; ~~● Tariffs and other trade barriers; ● Export controls; ● Political and economic instability; and ● Late delivery of our products.~~

	●	Tariffs and other trade barriers;

	●	Export controls;

	●	Political and economic instability; and

	●	Late delivery of our products.

We utilize third party manufacturing plants for silicon for the manufacturing our products, which, in the event of growth would need to use large quantities of silicon, for which raw material shortages may occur.

While we currently use silicon in our products, and no shortage currently exists of these materials, there can be no assurances that there will not be a shortage in the future, which may materially impact our manufacturing capabilities, growth prospects, and ability to generate revenue in the future.

Risks Related to our Securities

Our board of directors has broad discretion to issue additional securities.

We are authorized under our certificate of incorporation to issue up to 605,000,000 shares consisting of 600,000,000 shares of common stock and 5,000,000 “blank check” shares of preferred stock. Shares of our blank check preferred stock provide the board of directors with broad authority to determine voting, dividend, conversion, and other rights. As of ~~October~~June 1330, ~~2022~~ 2023, we have issued and outstanding ~~647~~2,~~886~~222,~~336~~951,485 shares of common stock; 610,000 shares of Series B Convertible Preferred Stock that are convertible into 30,500,000 shares of common stock at the election of the holder; and 65,425 shares of shares of Series C Convertible Preferred Stock. Additionally, we have 4516,~~997~~935,~~852~~352 shares of common stock reserved upon the exercise of outstanding purchase warrants. Accordingly, as of June 30, ~~2022~~2023 we are entitled to issue up to 1177,~~752~~048,~~113,664~~515 additional shares of common stock, and 4,390,000 additional shares of “blank check” preferred stock. Our board may generally issue those common and preferred shares, or convertible securities to purchase those shares, without further approval by our shareholders. Any additional preferred shares we may issue could have such rights, preferences, privileges, and restrictions as may be designated from time-to-time by our board, including preferential dividend rights, voting rights, conversion rights, redemption rights and liquidation provisions.

It is likely that we will issue additional securities to raise capital in order to further our business plans. It is also likely that we will issue additional securities to directors, officers, employees, and consultants as compensatory grants in connection with their services. Any issuances could be made at a price that reflects a discount to, or a premium from, the then-current market price of our common stock. These issuances would dilute the percentage ownership interest of our current shareholders, which would have the effect of reducing your influence on matters on which our stockholders vote and might dilute the net tangible book value per share of our common stock.

If securities or industry analysts do not publish research or reports or if they publish unfavorable research or reports, an active market for our common stock may not develop and the price of our common stock could decline.

We are a small company which is relatively unknown to stock analysts, stockbrokers, institutional investors and others in the investment community that generate or influence sales volume. Even if we come to the attention of such persons, they may be reluctant to follow or recommend an unproven company such as ours until such time as we became more seasoned and viable. Generally, the trading market for a company’s securities depends in part on the research and reports that securities or industry analysts publish. We currently have limited research coverage by securities and industry analysts. As a consequence, there may be periods of time when trading activity in our shares is minimal or non-existent, as compared to a seasoned issuer with significant research coverage. We cannot give you any assurance that a broader or more active public trading market for our common stock will develop or if developed, will be sustained, or that current trading levels could be sustained or not diminish. In addition, in the event any analyst downgrades our securities, the price of our shares would likely decline. If one or more of these analysts ceases to cover us or fails to publish regular reports on us, interest in the purchase of our securities could decrease, which could cause the price of our common stock and its trading volume, if any, to decline.

Our common stock may be considered a “penny stock,” and may be subject to additional sale and trading regulations that may make it more difficult to sell.

Our common stock may be considered a “penny stock.” The principal result or effect of being designated a penny stock is that securities broker-dealers participating in sales of our common stock may be subject to the penny stock regulations set forth in Rules 15g-2 through 15g-9 promulgated under the Exchange Act. For example, Rule 15g-2 requires broker-dealers dealing in penny stocks to provide potential investors with a document disclosing the risks of penny stocks and to obtain a manually signed and dated written receipt of the document at least two business days before effecting any transaction in a penny stock for the investor’s account. Moreover, Rule 15g-9 requires broker-dealers in penny stocks to approve the account of any investor for transactions in such stocks before selling any penny stock to that investor. This procedure requires the broker-dealer to (i) obtain from the investor information concerning his or her financial situation, investment experience and investment objectives; (ii) reasonably determine, based on that information, that transactions in penny stocks are suitable for the investor and that the investor has sufficient knowledge and experience as to be reasonably capable of evaluating the risks of penny stock transactions; (iii) provide the investor with a written statement setting forth the basis on which the broker-dealer made the determination in (ii) above; and (iv) receive a signed and dated copy of such statement from the investor, confirming that it accurately reflects the investor’s financial situation, investment experience and investment objectives. Compliance with these requirements may make it more difficult and time consuming for holders of our common stock to resell their shares to third parties or to otherwise dispose of them in the market or otherwise.

Our CEO and Chairman, as the sole holder of our Series B Convertible Preferred Stock, controls our company.

Chaya Hendrick, our CEO and Chairman, holds (via shares in her name or shares in the name of an entity she controls - Applied Cryptography, Inc. (“ACI”)) all 610,000 shares of Series B Convertible Preferred Stock outstanding. The outstanding shares of Series B Convertible Preferred Stock are entitled to vote on any matter with the holders of Common Stock voting together as one (1) class and shall have that number of votes (identical in every other respect to the voting rights of the holder of common stock entitled to vote at any regular or special meeting of Stockholders) equal to that number of common shares which is not less than 51% of the vote required to approve any action, which Nevada law provides may or must be approved by vote or consent of the common shares or the holders of other securities entitled to vote, if any. Each share of Series B Convertible Preferred Stock is convertible, at the option of the holder, into fifty (50) shares of Common Stock upon the satisfaction of certain conditions and for purposes of determining a quorum of a shareholder meeting, the outstanding shares of Series B Convertible Preferred Stock shall be deemed the equivalent of 51% of all shares of the Company’s Common Stock entitled to vote at such meetings. Accordingly, Ms. Hendrick can (without the approval of our other shareholders) elect our entire Board of Directors and determine the outcome of various matters submitted to shareholders for approval, including fundamental corporate transactions. Voting control by Ms. Hendrick may discourage certain types of transactions involving an actual or potential change in control of us, including transactions in which the holders of our common stock might receive a premium for their shares over prevailing market prices.

Failure to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our business and operating results and stockholders could lose confidence in our financial reporting.

Effective internal controls are necessary for us to provide reliable financial reports and effectively prevent fraud. If we cannot provide reliable financial reports or prevent fraud, our operating results could be harmed. Failure to achieve and maintain an effective internal control environment, regardless of whether we are required to maintain such controls, could also cause investors to lose confidence in our reported financial information, which could have a material adverse effect on our stock price. The Company’s management assessed the design and operating effectiveness of internal control over financial reporting as of June 30, ~~2022~~2023, based on the framework set forth in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on that assessment, management concluded that, during the period covered by this report, such internal controls and procedures were not entirely effective as of June 30, ~~2022~~2023.

We have not paid dividends on our common stock in the past and do not expect to pay dividends on our common stock for the foreseeable future. Any return on investment may be limited to the value of our common stock.

No cash dividends have been paid on our common stock. We expect that any income received from operations will be devoted to our future operations and growth. We do not expect to pay cash dividends on our common stock in the near future. Payment of dividends would depend upon our profitability at the time, cash available for those dividends, and other factors as our board of directors may consider relevant. If we do not pay dividends, our common stock may be less valuable because a return on an investor’s investment will only occur if our stock price appreciates.

The requirements of being a public company may strain our resources, divert management’s attention, and affect our ability to attract and retain qualified board members.

The Exchange Act requires, among other things, that we file annual, quarterly, and current reports with respect to our business and financial condition. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal controls for financial reporting. For example, Section 404 of the Sarbanes-Oxley Act of 2002 requires that our management report on, and our independent auditors attest to, the effectiveness of our internal controls structure and procedures for financial reporting. Section 404 compliance may divert internal resources and will take a significant amount of time and effort to complete. We may not be able to successfully complete the procedures and certification and attestation requirements of Section 404 by the time we will be required to do so. If we fail to do so, or if in the future our chief executive officer, chief financial officer or independent registered public accounting firm determines that our internal controls over financial reporting are not effective as defined under Section 404, we could be subject to sanctions or investigations by the SEC or other regulatory authorities. Furthermore, investor perceptions of our company may suffer, and this could cause a decline in the market price of our common stock. Irrespective of compliance with Section 404, any failure of our internal controls could have a material adverse effect on our stated results of operations and harm our reputation. If we are unable to implement these changes effectively or efficiently, it could harm our operations, financial reporting or financial results and could result in an adverse opinion on internal controls from our independent auditors. We may need to hire a number of additional employees with public accounting and disclosure experience in order to meet our ongoing obligations as a public company, which will increase costs. Our management team and other personnel will need to devote a substantial amount of time to new compliance initiatives and to meeting the obligations that are associated with being a public company, which may divert attention from other business concerns, which could have a material adverse effect on our business, financial condition, and results of operations. In addition, because our management team has limited experience managing a public company, we may not successfully or efficiently manage our transition into a public company.

Item 1B.

Unresolved Staff Comments.

Not Applicable.

1718

Item 2.

Properties.

Our principal office is located at 3960 Howard Hughes Parkway, Suite 500, Las Vegas, Nevada 89109. We currently lease this property at a rate of approximately $1,100 per month. We believe that our existing office facility is adequate for our current needs and that additional space will be available if, and when needed.

Item 3.

Legal Proceedings.

From time to time, we may be a defendant or plaintiff in various legal proceedings arising in the normal course of our business. As of the date of this Annual Report, there are no material pending legal or governmental proceedings relating to us or properties to which we are a party, and, to our knowledge, there are no material proceedings to which any of our directors, executive officers or affiliates are a party adverse to us or which have a material interest adverse to us.

Item 4.

Mine Safety Disclosures.

Not Applicable

1819

PART II

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information

As of ~~September~~June 1530, ~~2022~~2023, ~~647~~2,~~886~~222,~~336~~951,485 shares of our common stock were issued and outstanding.

There is no “established trading market” for shares of the Company’s common stock. As of June 30, ~~2022~~2023, the Company’s common stock was quoted on the OTC Link LLC alternative trading system operated by OTC Markets Group, Inc. under the symbol “SMME” at the OTCQB level. No assurance can be given that any “established trading market” for the Company’s common stock will develop or be maintained.

The range of high and low closing bid quotations for the Company’s common stock during each quarter of the fiscal years ended June 30, ~~2022~~2023 and ~~2021~~2022, is shown below, as quoted by http://finance.yahoo.com. Prices are inter-dealer quotations, without retail mark-up, markdown or commissions and may not represent actual transactions.

Stock Quotations

Quarter Ended	High		Low
September 30, 2020	$	0.02	$	0.01
December 31, 2020	$	0.02	$	0.01
March 31, 2021	$	0.05	$	0.02
June 30, 2021	$	0.03	$	0.02
September 30, 2021	$	0.02	$	0.01
December 31, 2021	$	0.02	$	0.01
March 31, 2022	$	0.04	$	0.01
June 30, 2022	$	0.01	$	0.0100
September 30, 2022	$	0.01	$	0.00
December 31, 2022	$	0.00	$	0.00
March 31, 2023	$	0.00	$	0.00
June 30, 2023	$	0.00	$	0.00

The future sale of the Company’s presently outstanding “unregistered” and “restricted” common stock by present members of management and persons who own more than five percent of the Company’s outstanding voting securities may have an adverse effect on any “established trading market” that may develop in the shares of the Company’s common stock.

Holders

As of ~~September~~June 1530, ~~2022~~2023, the Company had approximately 1,~~131~~159 shareholders of record of common stock, including shares held in “street name” by banks, brokerage clearing houses, depositories or otherwise in unregistered form. The Company does not know the beneficial owners of such shares, or the number of beneficial holders of such shares.

Dividend Distributions

We have not historically distributed dividends to stockholders, nor do we intend to do so in the foreseeable future.

Securities Authorized for Issuance Under Equity Compensation Plans

The Company does not have any securities authorized for issuance under equity compensation plans.

1920

Penny Stock

Our common stock is considered “penny stock” under the rules the Securities and Exchange Commission (the “SEC”) under the Securities Exchange Act of 1934. The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or quoted on the NASDAQ Stock Market System, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or quotation system. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock, to deliver a standardized risk disclosure document prepared by the Commission, that:

	-	contains a description of the nature and level of risks in the market for penny stocks in both public offerings and secondary trading;

	-	contains a description of the broker’s or dealer’s duties to the customer and of the rights and remedies available to the customer with respect to a violation to such duties or other requirements of Securities’ laws; contains a brief, clear, narrative description of a dealer market, including bid and ask prices for penny stocks and the significance of the spread between the bid and ask price;

	-	contains a toll-free telephone number for inquiries on disciplinary actions;

	-	defines significant terms in the disclosure document or in the conduct of trading in penny stocks; and

	-	contains such other information and is in such form, including language, type, size and format, as the Commission shall require by rule or regulation.

The broker-dealer also must provide, prior to effecting any transaction in a penny stock, the customer with:

	-	bid and offer quotations for the penny stock;

	-	the compensation of the broker-dealer and its salesperson in the transaction;

	-	the number of shares to which such bid and ask prices apply, or other comparable information relating to the depth and liquidity of the marker for such stock; and

	-	monthly account statements showing the market value of each penny stock held in the customer’s account.

In addition, the penny stock rules that require that prior to a transaction in a penny stock not otherwise exempt from those rules; the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written acknowledgement of the receipt of a risk disclosure statement, a written agreement to transactions involving penny stocks, and a signed and dated copy of a written suitably statement.

These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our stock.

Transfer Agent

The transfer agent for our common stock is Worldwide Stock Transfer, LLC, One University Plaza, Suite 505, Hackensack, NJ 07601.

Rule 10B-18 Transactions

During the fiscal year ended June 30, 2022, there were no repurchases of the Company’s common stock by the Company.

2021

Recent Sales of Unregistered Securities

During the three months ended June 30, ~~2022~~2023, we issued securities that were not registered under the Securities Act as described below. All of the securities discussed in this Item 5 were issued in reliance on the exemption under Section 4(a)(2) of the Securities Act as there was no general solicitation and the shares were issued in private offering transaction. Additionally, the common stock issuances described below upon conversion of preferred stock were also issued in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act as the shares of common stock were issued solely in exchange for other securities of the Company held by the stockholder, there was no additional consideration for each of the exchanges, and there was no remuneration for the solicitation of each of the exchanges.

On ~~May~~ April 428, ~~2022~~2023, the Company issued 373,~~684~~113,~~211~~423 shares of common stock to ~~Geneva~~Mast ~~Roth~~Hill ~~Remark~~Fund upon its ~~conversion~~note ofpayable ~~16,300 Preferred C shares~~conversion.

On May 133, ~~2022~~2023, the Company issued 455,~~565~~692,~~217~~058 shares of common stock to ~~Geneva~~AJB ~~Roth~~Capital ~~Remark~~ upon its ~~conversion~~note ofpayable ~~20,000 Preferred C shares~~conversion.

On May 189, ~~2022~~2023, the Company issued 218,~~000~~073,~~000~~976 shares of common stock to anMast ~~investor~~Hill ~~for~~Fund ~~$5,000~~upon ~~cash~~its note payable conversion.

On May 1825, ~~2022~~2023, the Company issued 1106,000,000 shares of common stock to anvarious ~~investor~~investors for ~~$5,000~~ cash.

On ~~May~~ June 187, ~~2022~~2023, the Company issued ~~125~~39,~~000~~833,325 shares of common stock to anvarious ~~investor~~investors for ~~$625~~ cash.

On ~~May~~ June 1820, ~~2022~~2023, the Company issued ~~250~~87,300,000 shares of common stock to anMast ~~investor~~Hill ~~for~~Fund ~~$1,250~~upon ~~cash~~its note payable conversion.

On ~~May~~ June 2421, ~~2022~~2023, the Company issued 355,~~714~~000,~~286~~000 shares of common stock to ~~Mitchell,~~various ~~Silberberg,~~investors ~~Knupp in exchange~~ for ~~legal services valued at $25,000~~cash.

On June 129, ~~2022~~2023, the Company issued 2144,~~187~~242,~~500~~825 shares of common stock to ~~Geneva~~AJB ~~Roth~~Capital ~~Remark~~ upon its ~~conversion~~note ofpayable ~~8,125 Preferred C shares~~conversion.

On June 7, 2022, the Company issued 5,526,316 shares of common stock to Geneva Roth Remark upon its conversion of 20,000 Preferred C shares.

On June 16, 2022, the Company issued 6,176,471 shares of common stock to Geneva Roth Remark upon its conversion of 20,000 Preferred C shares.

On June 22, 2022, the Company issued 2,305,743 of common stock to Geneva Roth Remark upon its conversion of 20,000 Preferred C shares.

Item 6.

Selected Financial Data

Not Applicable as we are a smaller reporting company.

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Our Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is provided in addition to the accompanying financial statements and notes to assist readers in understanding our results of operations, financial condition, and cash flows. MD&A is organized as follows:

● Company Overview - Discussion of our business plan and strategy in order to provide context for the remainder of MD&A. ● Critical Accounting Policies - Accounting policies that we believe are important to understanding the assumptions and judgments incorporated in our reported financial results and forecasts. ● Results of Operations - Analysis of our financial results comparing the year ended June 30, ~~2022~~2023 and June 30, ~~2021~~2022. ● Liquidity and Capital Resources - Liquidity discussion of our financial condition and potential sources of liquidity.

2122

Company Overview

Business

SmartMetric, Inc. was incorporated pursuant to the laws of Nevada on December 18, 2002. “SmartMetric is a development stage company engaged in the technology industry. SmartMetric’s main products are a fingerprint sensor activated payments card and security card with a finger sensor and fully functional fingerprint reader embedded inside the card. The SmartMetric biometric cards have a rechargeable battery allowing for portable biometric identification and card activation. This card is referred to as a biometric card or the SmartMetric Biometric Card.”

To date, we have devoted substantially all of our efforts and financial resources to the development of our SmartMetric Card. Since our inception in 2002, we have generated no revenue from product sales and have funded our operations principally through the private sales of our equity securities. We have never been profitable and, as of June 30, ~~2022~~2023, we had an accumulated deficit of approximately $30(31,~~503~~431,~~856~~438). We expect to continue to incur significant operating losses for the foreseeable future as we continue the development of our technologies and advance them to market.

~~Our cash~~SmartMetric ~~and~~has ~~cash~~created ~~equivalents~~earlier ~~balance~~versions atof ~~June 30,~~its ~~2022~~credit/debit ~~was~~biometric ~~approximately~~fingerprint ~~$126,791~~activated ~~representing~~credit 72card.3% ofThe ~~total~~latest ~~assets. Notwithstanding our recent capital raises~~version, ~~based~~designed ~~on our current expected level of operating expenditures, we expect~~ to be ~~able~~compliant towith ~~fund~~the ~~our~~requests ~~operations into~~of ~~the~~a ~~quarter~~major ~~beginning~~global ~~April 1~~payments network, ~~2023.~~is ~~This~~now ~~period~~in ~~could~~the befinal ~~shortened~~stages ifof ~~there~~development ~~are~~so ~~any~~that ~~significant~~it ~~increases~~can inbe ~~spending that~~presented ~~were~~to ~~not~~the ~~anticipated~~network orand ~~other~~various ~~unforeseen~~card ~~events~~issuing banks.

Our cash and cash equivalents balance at June 30, 2023 was approximately $20,012 representing 32% of total assets. Notwithstanding our recent capital raises, based on our current expected level of operating expenditures, we expect to be able to fund our operations into the quarter beginning December 31, 2023. This period could be shortened if there are any significant increases in spending that were not anticipated or other unforeseen events.

We anticipate raising additional cash through the private or public sales of equity or debt securities to continue to fund our operations and the development of our technologies. There is no assurance that financing will be available to us when needed in order to allow us to continue our operations, or if available, on terms acceptable to us. If we do not raise sufficient funds in a timely manner, we may be forced to curtail operations, delay or stop our ongoing clinical trials, cease operations altogether, or file for bankruptcy. We currently do not have commitments for future funding from any source.

Going Concern

The consolidated financial statements do not include any adjustments relating to the carrying amounts of recorded assets or the carrying amounts and classification of recorded liabilities that may be required should the Company be unable to continue as a going concern.

As shown in the accompanying consolidated financial statements the Company has incurred recurring losses available to common shareholders of $1935,~~687,348~~396 and $~~924~~1,~~728~~ 636,678 for the period ending June 30, ~~2022~~2023 and ~~2021~~2022, respectively, and has incurred a cumulative loss of $3031,~~496~~431,~~042 since inception (December 18, 2002)~~438. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year from the date of this filing. The Company is currently in the development stage and has spent a substantial portion of its time in the development of its technology.

There is no guarantee that the Company will be able to raise enough capital or generate revenues to sustain its operations.

Management believes that the Company’s capital requirements will depend on many factors. These factors include the final phase of development and mass production being successful as well as product implementation and distribution. Management plans to continue its relationship with Geneva Roth Remark in order to raise capital beyond exclusively private placement stock sales.

2223

Critical Accounting Policies

We have prepared our financial statements in conformity with accounting principles generally accepted in the United States, which requires management to make significant judgments and estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. We base these significant judgments and estimates on historical experience and other applicable assumptions we believe to be reasonable based upon information presently available. These estimates may change as new events occur, as additional information is obtained and as our operating environment changes. These changes have historically been minor and have been included in the financial statements as soon as they became known. Actual results could materially differ from our estimates under different assumptions, ~~judgments~~judgements, or conditions.

All of the Company’s significant accounting policies are discussed in Note 2, Summary of Significant Accounting Policies, to our financial statements, included elsewhere in this Annual Report. We have identified the following as our significant accounting policies and estimates, which are defined as those that are reflective of significant judgments and uncertainties, are the most pervasive and important to the presentation of our financial condition and results of operations and could potentially result in materially different results under different assumptions, ~~judgments~~judgements or conditions.

We believe the following critical accounting policies reflect our more significant estimates and assumptions used in the preparation of our financial statements:

Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Actual results may differ from those estimates.

Research and Development Costs - Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation, and consulting costs.

Earnings Per Share - In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive.

Patent Impairment - When the carrying balance of the Company’s patent is more than what it could be sold for on the open market and/or is not recoverable through future use, the Company decreases its value. In determining whether the carrying value is not recoverable, the Company estimates the sum of the expected cash flows from the use of the patent or its possible sale. If the results in an amount less that the patent’s value on the financial statements, the Company will deem the patent’s carrying value on the balance sheet to be impaired by the amount that the carrying value exceeds the fair market value of the asset. The decrease in the patent’s value will then be included as a loss in the Company’s profit and loss statement. The Company had noa patent asset of $33,750 (net) recorded at June 30, ~~2022~~2023.

Cash - The Company considers all highly liquid debt instruments and other short-term investments with an initial maturity of three months or less to be cash equivalents. Any amounts of cash in financial institutions which exceed FDIC insured limits exposes the Company to cash concentration risk. The Company had no cash equivalents at June 30, ~~2022~~2023 and ~~2021~~2022.

2324

Result of Operations

Year Ended June 30, ~~2022~~2023 Compared to the Year Ended June 30, ~~2021~~2022

Our results of operations have varied significantly from year to year and quarter to quarter and may vary significantly in the future. We did not have revenue during the years ending June 30, ~~2022~~2023 and ~~2021~~2022. We did not generate any revenues during the years ending June 30, ~~2022~~2023 and ~~2021~~2022. Net loss for the years ended June 30, ~~2022~~2023 and ~~2021~~2022 were $1935,~~687,348~~396 and $~~944~~1,~~203~~636,678, respectively, resulting from the operational activities described below.

Operating Expenses

Operating expenses were $1810,~~133,502~~903 and $~~821~~1,~~824~~117,808 during the years ended June 30, ~~2022~~2023 and ~~2021~~2022, respectively. The ~~increase~~decrease in operating expenses is the result of ~~increasing~~decreasing research and development expenses and general and administrative expenses as a result of increasing product development activities during the fiscal year ended June 30, ~~2022~~2023, as compared to June 30, ~~2021~~2022, as set forth below.

	Year Ended June 30,				Change in ~~2022~~2023 Versus ~~2021~~2022
	2022		2021		$			%
	2023		2022		$			%
Operating Expenses
Research and development	$	~~128~~125,~~616~~867	$	76128,~~344~~616	$	52(2,~~272~~749	)		68(2.51	)%
General and administrative		~~814~~495,~~886~~036		~~555~~799,~~480~~192		~~259~~(304,~~406~~157	)		46(87.70	)%
Officer salary		190,000		190,000		—-			(0	)%
Total operating expense	$	1810,~~133,502~~903	$	~~821~~1,~~824~~117,808	$	~~311~~(298,~~678~~571	)		37(26.97	)%

Research and Development

Research and development expenses were $~~128~~125,~~616~~867 and $76128,~~344~~616 for the years ended June 30, ~~2022~~2023 and ~~2021~~2022, respectively. The ~~increase~~ decrease of $522,~~272~~749, or 682.51%, in ~~2022~~2023 compared to ~~2021~~2022 was primarily attributable to ana ~~increase~~decrease in engineering costs associated with ~~increased~~ decreased development efforts in the most recent fiscal year as compared to the prior fiscal year.

Our research and development expenses consist primarily of expenditures related to engineering development of our card product.

General and Administrative

General and administrative expenses were $~~814~~495,~~886~~036 and $~~555~~799,~~480~~192 for the years ended June 30, ~~2022~~2023 and ~~2021~~2022, respectively. The ~~increase~~ decrease of $~~259~~304,~~406~~157 or 4687.70%, in ~~2022~~2023 compared to ~~2021~~2022 was primarily the result of ana ~~increase~~decrease in consulting expenses for research and development during the most recent fiscal year as compared to the prior fiscal year.

Our general and administrative expenses consist primarily of expenditures related to employee compensation, legal, accounting and tax, other professional services, and general operating expenses.

Officer salary was $190,000 for the fiscal years ended June 30, ~~2022~~2023 and ~~2021~~2022, respectively.

2425

Liquidity and Capital Resources

We have incurred losses since our inception in 2002 as a result of significant expenditures for operations and research and development and the lack of any revenue. We have an accumulated deficit of ~~approximately~~ $~~30.5~~(31,431,438) million as of June 30, ~~2022~~2023, and anticipate that we will continue to incur additional losses for the foreseeable future. Through June 30, ~~2022~~2023, we have funded our operations through the private sale of our equity securities and exercise of options and warrants, resulting in gross proceeds of approximately $2729.9 million. Cash and cash equivalents at June 30, ~~2022~~2023 were $~~126~~20,~~791~~012.

We are actively seeking sources of financing to fund our continued operations and research and development programs. To raise additional capital, we may sell shares of equity or debt securities. There can be no assurance that we will be able to complete any financing transaction in a timely manner or on acceptable terms or otherwise. If we are not able to raise additional cash, we may be forced to further delay, curtail, or cease development of our product candidates, or cease operations altogether.

	Year Ended June 30,
	2022			2021
	2023			2022
Cash at beginning of period	$	10126,~~325~~791		$	7110,~~377~~325
Net cash used in operating activities		(1247,~~042,743~~140	)		(~~548~~1,~~107~~002,770	)
Net cash used in investing activities		—			—
Net cash used in investing activities –		(34,916	)		-
Net cash provided by financing activities		1287,~~159,209~~987			~~487~~1,~~055~~140,067
Cash at end of period	$	126,791		$	10,325
Non Cash Financing expenses		(112,710	)
Cash at end of period	$	20,012		$	126,791

Net Cash Used in Operating Activities

Net cash used in operating activities was $1 (247,~~042,743~~140) and $~~548~~1,~~107~~002,770 for the years ended June 30, ~~2022~~2023 and ~~2021~~2022, respectively. The ~~increase~~ decrease of $~~494~~ 755,~~636~~629 in cash used during ~~2022~~2023 compared to ~~2021~~2022 was primarily attributable to ~~higher~~lower consulting and legal expenses during the most recent fiscal year as compared to the prior fiscal year.

Net Cash Used in Investing Activities

Cash used in investing activities was $034,916 and $0 for years ended June 30, ~~2022~~2023 and ~~2021~~2022, respectively.

Net Cash Provided by Financing Activities

Net cash provided by financing activities was $1 287,~~159,209~~987 for the year ended June 30, ~~2022~~2023 compared to $~~506~~ 1,~~530~~140,067 for the year ended June 30, ~~2021~~2022. The ~~increase~~decrease of $~~652~~ 852,~~679~~080 was due to ~~increased~~decreased private placement sales during the most recent fiscal year as compared to the prior fiscal year. We are actively seeking sources of financing to fund our continued operations and research and development programs.

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk.

Not Applicable.

Item 8.

Financial Statements and Supplementary Data.

Our audited consolidated financial statements for the fiscal years ended June 30, ~~2022~~2023 and ~~2021~~2022, together with the reports of the independent registered public accounting firms thereon and the notes thereto, are presented beginning at page F-1.

2526

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

There are no reportable events under this item for the fiscal year ended June 30, 2023.

Item 9A.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain limited “disclosure controls and procedures,” as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

In connection with the preparation of this Annual Report on Form 10-K for the year ended June 30, ~~2022~~2023, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(c) and 15d-15(e) under the Exchange Act) are not effective to ensure that information required to be disclosed by us in report that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the U.S. Securities and Exchange Commission’s rules and forms and to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer, as appropriate to allow timely decisions regarding required disclosure.

Management’s Annual Report on Internal Control Over Financial Reporting

The management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting (“ICFR”) for the Company. Our internal control system was designed to, in general, provide reasonable assurance to the Company’s management and board regarding the preparation and fair presentation of published financial statements, but because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Our management assessed the effectiveness of the Company’s internal control over financial reporting as of June 30, ~~2022~~2023. The framework used by management in making that assessment was the criteria set forth in the document entitled “2013 Internal Control – Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on that assessment, management concluded that, during the period covered by this report, such internal controls and procedures were not effective as of June 30, ~~2022~~2023.

A material weakness is a deficiency, or a combination of deficiencies, within the meaning of Public Company Accounting Oversight Board (“PCAOB”) Auditing Standard AS 2201, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Management has not identified any material weaknesses as of June 30, 2022 and our internal controls over financial reporting were effective at the reasonable assurance level.27

A material weakness is a deficiency, or a combination of deficiencies, within the meaning of Public Company Accounting Oversight Board (“PCAOB”) Auditing Standard AS 2201, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Management has not identified any material weaknesses as of June 30, 2023 and our internal controls over financial reporting were effective at the reasonable assurance level.

This Annual Report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm as we are a smaller reporting company and are not required to provide the report.

Limitations on Controls

Management does not expect that the Company’s disclosure controls and procedures or the Company’s internal control over financial reporting will prevent or detect all error and fraud. Any control system, no matter how well designed and operated, is based upon certain assumptions, and can provide only reasonable, not absolute, assurance that its objectives will be met. Further, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. The Company’s disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives and the Company’s chief executive officer and chief financial officer have concluded that the Company’s disclosure controls and procedures are not effective.

Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions are being performed by separate individuals. Management evaluated the impact of our limitation to have segregation of duties in all of our financially significant processes and have concluded that this control did not meet the criteria of a material weakness.

Notwithstanding the assessment that our disclosure controls and procedures and our internal controls over financial reporting were not effective and that there are material weaknesses as identified herein, we believe that our consolidated financial statements contained in this annual report fairly present our financial position, results of operations and cash flows for the periods covered thereby in all material respects.

Changes in Internal Controls

During the fiscal year ended June 30, ~~2022~~2023, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting

Item 9B.

Other Information

None.

2728

PART III

Item 10. Directors, Executive Officers, and Corporate Governance

The following table sets forth the names and ages of the members of our Board of Directors and our executive officers and the positions held by each. Each member of the Board of Directors serves for a term of one year, or until his or her successor has been duly elected and has been qualified. Each of our officers serve until they are replaced by the Board of Directors.

Name	Age	Position with the Company
Chaya Hendrick	6667	President, Chief Executive Officer and Chairman of the Board
Jay M. Needelman, CPA	5455	Chief Financial Officer, Director
Elizabeth Ryba	7172	Director

CHAYA HENDRICK has been President, Chief Executive Officer, and Chairman of the Board of Directors of SmartMetric since the Company’s inception in 2002. C. Hendrick has served as President and CEO of Smart Micro Chip, Inc., an Australian corporation from 2000 to 2002. From 1999 to 2001, C. Hendrick was President and Chief Executive Officer of Smarticom Inc. and FastEcom, Inc., Australian corporations. From 1994 to 1998, C. Hendrick served as executive officer of Applied Computing Science (Australia), an Australian company involved in e-commerce systems, research and development. Ms. Hendrick founded Asset Developments a property development company that created and sold regional residential land subdivisions. The last being a 1,000-acre subdivision named Claire Valley Estates in the Canberra region of Australia. All of the property development projects were funded by C. Hendrick and were financially profitable. C. Hendrick attended Dandenong College in Australia.

We believe Ms. Hendrick is qualified to serve on our Board due to her extensive experience in technology development and as an executive at technology companies.

JAY M. NEEDELMAN, CPA, has been the Chief Financial Officer and a director of SmartMetric since 2007. Mr. Needelman has over 29 31 years of experience in public accounting. A 1991 graduate of Florida State University in Tallahassee, Fl, Mr. Needelman began his career in public accounting in Miami, Fl, in 1991. After working for two different firms, Mr. Needelman founded his own firm in late 1992.

We believe Mr. Needelman is qualified to serve on our Board due to his financial expertise.

ELIZABETH RYBA has been a director of SmartMetric since April 5, 2006. From 2015 to the present, Ms. Ryba has been Vice President of Marketing at the Design and Decoration Building in New York, one of the premier destinations for luxury interior design showrooms in the country. From 2006 to 2015, Ms. Ryba had marketing positions at two luxury home decor brands. Ms. Ryba was a promotion director at Hearst Publishing from 2002 through 2005. Between 2001 and 2004, Ms. Ryba was a consultant at Stratus Rewards Credit Cards where she launched a Visa Luxury credit card where points were redeemable on private jets. Between 2000 and 2001, Ms. Ryba worked as a Marketing Consultant for SpaFinder. From 1991 through 1999, Ms. Ryba worked at Master Card where she launched a Smart Card in Australia. Ms. Ryba received her M.S. in Marketing from the University of Illinois, and her B.A. in English from the State University of New York at Stony Brook.

We believe Ms. Ryba is qualified to serve on our Board due to her extensive experience in the credit card industry as well as her extensive experience in marketing in the luxury sector which we believe is a sector to which we may be able to sell our products.

Family Relationships

There are no family relationships among officers or directors of the Company.

Committees of the Board

Our business, property and affairs are managed by or under the direction of the Board. Members of the Board are kept informed of our business through discussion with the chief executive and financial officers and other officers, by reviewing materials provided to them and by participating at meetings of the Board. We have not previously had an audit committee, compensation committee or nominations and governance committee.

Audit Committee

We currently do not have an acting audit committee, and our Board of Directors currently acts as our audit committee.

Audit Committee Financial Expert

We do not have an audit committee and thus do not have an audit committee financial expert.

Compensation Committee

We do not presently have a compensation committee. Our Board currently acts as our compensation committee.

Director Independence

For purposes of determining independence, we have adopted the definition of “independence” contained in the NASDAQ Market Place Rules. Pursuant to the definition, the company has determined that Elizabeth Ryba qualifies as independent.

Code of Ethics

The Company has adopted a Code of Ethics that applies to its Chief Executive Officer and Chief Financial Officer. A copy of the Company’s code of ethics is available to any person without charge upon written request to the Company at SmartMetric, Inc., 3960 Howard Hughes Parkway, Suite 500, Las Vegas, NV, 89109. Attn: Secretary.

Involvement in Certain Legal Proceedings

To the best of our knowledge, none of our directors or executive officers has, during the past ten years:

● been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offenses); ● had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation, or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time; ● been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity; ● been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;

●

been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;

	●	been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

	●	been the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

Except as set forth in our discussion below in “Certain Relationships and Related Transactions, and Director Independence” none of our directors or executive officers has been involved in any transactions with us or any of our directors, executive officers, affiliates, or associates which are required to be disclosed pursuant to the rules and regulations of the SEC.

2931

Item 11.

Executive Compensation

Summary Compensation Table

Officer. The table below sets forth, for the fiscal years ended June 30, ~~2022~~2023 and ~~2021~~2022, the compensation earned by each person acting as our Chief Executive Officer and Chief Financial Officer. The Company’s only employee is our Chief Executive

Name and Principal Position	Fiscal Year Ended	Salary ($)	~~Salary ($)~~		Bonus ($)	~~Bonus ($)~~		Stock Awards ($)	~~Stock Awards ($)~~		Option Awards ($)	~~Option Awards ($)~~		Non-equity Incentive Plan Compensation ($)	~~Non-equity Incentive Plan Compensation ($)~~		Nonqualified Deferred Compensation Earnings ($)	~~Nonqualified Deferred Compensation Earnings ($)~~		All Other Compensation ($)	~~All Other Compensation ($)~~		Total ($)	~~Total ($)~~
Chaya Hendrick	~~2022~~2023	$	$190,000	~~190,000~~		-0-	~~-0-~~		-0-	~~-0-~~		-0-	~~-0-~~		-0-	~~-0-~~		-0-	~~-0-~~	$	$-0-	~~-0-~~	$	$190,000	~~190,000~~
(President, Chief Executive Officer, Chairman of the Board (1)	2021		$	190,000			-0-			-0-			-0-			-0-			-0-		$	-0-		$	190,000
(President, Chief Executive Officer, Chairman of the Board)	2022	$	190,000			-0-			-0-			-0-			-0-			-0-		$	-0-		$	190,000
Jay Needelman	~~2022~~2023	$	$15,000	~~15,000~~		-0-	~~-0-~~		-0-	~~-0-~~		-0-	~~-0-~~		-0-	~~-0-~~		-0-	~~-0-~~		-0-	~~-0-~~	$	$15,000	~~15,000~~
(Chief and Principal Financial Officer, Director) (5)	2021		$	15,000			-0-			-0-			-0-			-0-			-0-			-0-		$	15,000
(Chief and Principal Financial Officer, Director)	2022	$	15,000			-0-			-0-			-0-			-0-			-0-			-0-		$	15,000

Outstanding Equity Awards at Fiscal Year End

None.

Chaya Hendrick Employment

Previous Employment Agreement

On July 1, 2012, the Company entered into an employment agreement (the “Prior Agreement”) with Chaya Hendrick, the Company’s Chief Executive Officer that expired on July 1, 2017. Pursuant to the Prior Agreement, Ms. Hendrick received an annual base salary of $190,000 per year. Ms. Hendrick was also entitled to receive a management fee equal to $50,000 per year beginning with the Company’s fiscal year ended June 30, 2012 and each fiscal year thereafter during the term of the Agreement provided that the Company has manufactured its first product. This fee was to increase by 25% per annum at the conclusion of each calendar year and was based on the continued manufacturing and sales of products by the Company. As of the end of the term of the Prior Agreement, no compensation was paid pursuant to this management fee.

Ms. Hendrick was also entitled to participate in any and all benefit plans, from time to time, in effect for senior management, along with vacation, sick and holiday pay in accordance with the Company’s policies established and in effect from time to time. The Company also provided Ms. Hendrick with the use of an automobile of Ms. Hendrick’s choice at a purchase price not to exceed $60,000. Executive’s employment with the Company was subject to termination at any time, with cause, as such terms are defined in the Prior Agreement.

The Prior Agreement may be terminated on 30 days’ notice by Ms. Hendrick but may only be terminated by the Company for “cause.” In the event that Ms. Hendrick’s employment was terminated by the Company, the Company was obligated to pay to Ms. Hendrick an amount equal to $350,000 plus salary remaining on the term of the Prior Agreement.

3032

Addendum to Prior Agreement

On September 30, 2015, the Company and Ms. Hendrick entered into an Addendum to the Agreement (the “Addendum”) pursuant to which in consideration for the issuance of 200,000 shares of the Company’s Series B Convertible Preferred Stock, Ms. Hendrick granted the Company the first right to purchase or license any patents (the “Patent Option”) relating to “Smartcards” which Ms. Hendrick (i) shall apply for with the relevant patent authorities during the term of the Agreement, and (ii) are currently applied for with the relevant patent authorities or pending as of the date of the Prior Agreement (the “Patent Rights”). In exchange for the Patent Option the Company agrees, during the term of the Prior Agreement, to pay for any fees and/or expenses related to the application for the Ms. Hendrick’s Patent Rights with the relevant patent authorities, including, but not limited to, legal or filing fees. If, upon the Company’s receipt of notice of any Patent Rights of Ms. Hendrick’s in writing (“Patent Notification”) the parties fail to successfully negotiate and execute a purchase or license agreement as it relates to the Patent Right that is the subject of such Patent Notification within 60 calendar days of the receipt of such Patent Notification, the Ms. Hendrick shall be permitted to retain or transfer the Patent Rights to a third party without any subsequent notice to the Company.

Amended and Restated Employment Agreement

On July 1, 2017, the Company and Ms. Hendrick entered into an amended and restated employment agreement (“Agreement”) with a duration of sixty (60) months. Pursuant to the Agreement, Ms. Hendrick shall receive (i) an annual base salary of $190,000, subject to adjustment at the end of each fiscal year at the discretion of the board of directors, with a minimum increase of 10% per annum for the duration of the term, (ii) an incentive management fee equal to $50,000 upon the Company manufacturing its first product, which shall increase by 25% per annum and based on the continued manufacturing and sales of products by our Company.

Additionally, Ms. Hendrick shall maintain certain rights to initiate, write, invent and / or create inventions separate from SmartMetric, Inc. and to retain the intellectual property rights of such patents, inventions, or new products.

The Agreement may be terminated on 30 days’ notice by Ms. Hendrick but may only be terminated by the Company for “cause.” In the event that Ms. Hendrick’s employment is terminated by the Company for such “cause,” the Company is obligated to pay to Ms. Hendrick an amount equal to $350,000 plus the remaining salary on the term of the Agreement.

Jay Needelman Contract

We currently have an oral agreement with Jay Needelman, our part-time Chief Financial Officer, whereby we pay Mr. Needelman an annual fee of $15,000 for his services, payable in quarterly installments of $3,750.

3133

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table sets forth certain information, as of ~~August~~June 530, ~~2021~~2023, with respect to the beneficial ownership of the outstanding common stock by (i) any holder of more than five (5%) percent; (ii) each of the Company’s executive officers and directors; and (iii) the Company’s directors and executive officers as a group. Except as otherwise indicated, each of the stockholders listed below has sole voting and investment power over the shares beneficially owned.

Amount and Nature of Beneficial Ownership

Title of Class	Name and Address of Beneficial Owner	Director/Officer	Number of Shares of Common Stock (1)			Percentage of Class (1)
	Directors and Executive Officers
Common Stock	Chaya Hendrick ~~(2)~~ 145 East Harmon Avenue, Unit 19620 Las Vegas, NV 89109	Chief Executive Officer, Chairman of the Board of Directors		89,127,778	(2)		134.80	%
Common Stock	Jay Needelman, CPA 520 West 47th Street Miami Beach, FL 33140	Director; Chief Financial Officer		-0-			0	%
Common Stock	Elizabeth Ryba 73 Brown Road Scarsdale, New York 10583	Director		40,000			*	%
	All Executive Officers and Directors as a Group (3 persons)			89,167,778			134.80	%
	5% Shareholders

*	Less than one percent (1%)

(1) In determining beneficial ownership of our common stock as of a given date, the number of shares shown includes shares of common stock which may be acquired on exercise of warrants or options or conversion of convertible securities within 60 days of that date. In determining the percent of common stock owned by a person or entity on June 30, ~~2022~~2023, (a) the numerator is the number of shares of the class beneficially owned by such person or entity, including shares which may be acquired within 60 days on exercise of warrants or options and conversion of convertible securities, and (b) the denominator is the sum of (i) ~~647~~2,~~886~~222,~~336~~951,485, the total shares of common stock outstanding on ~~September~~June 1530, ~~2022~~2023, and (ii) the total number of shares that the beneficial owner may acquire upon conversion of any preferred stock and on exercise of the warrants and options. Unless otherwise stated, each beneficial owner has sole power to vote and dispose of its shares.

(2)

The 89,127,778 shares of common stock include (i) 58,627,778 of Common Stock and; (ii) 610,000 shares of Series B Convertible Preferred Stock convertible into 30,500,000 shares of common stock held by Applied Cryptography, Inc. (“ACI”) and / or Chaya Hendrick. The outstanding shares of Series B Convertible Preferred Stock are entitled to vote on any matter with the holders of Common Stock voting together as one (1) class and shall have that number of votes (identical in every other respect to the voting rights of the holder of common stock entitled to vote at any regular or special meeting of Stockholders) equal to that number of common shares which is not less than 51% of the vote required to approve any action, which Nevada law provides may or must be approved by vote or consent of the common shares or the holders of other securities entitled to vote, if any. Each share of Series B Convertible Preferred Stock is convertible, at the option of the holder, into fifty (50) shares of Common Stock upon the satisfaction of certain conditions and for purposes of determining a quorum of a shareholder meeting, the outstanding shares of Series B Convertible Preferred Stock shall be deemed the equivalent of 51% of all shares of the Company’s Common Stock entitled to vote at such meetings. Our Chairman and Chief Executive Officer, has sole voting and dispositive power over all of the shares beneficially owned by ACI.

3234

Item 13.

Certain Relationships and Related Transactions, and Director Independence

Information regarding disclosure of an employment relationship or transaction involving an executive officer and any related compensation solely resulting from that employment relationship or transaction is incorporated by reference from the section of this Annual Report on Form10-K entitled “Executive Compensation.”

Information related to “Director Independence” is incorporated by reference from the section of this this Annual Report on Form10-K entitled “Directors, Executive Officers, and Corporate Governance.”

Related Party Transactions:

● Chaya Hendrick, our CEO has made cash advances to the Company periodically in exchange for promissory notes of such face values. As of the years ended June 30, ~~2022~~2023 and ~~2021~~2022, we owed $313,~~297~~814 and $0, respectively. These notes bear interest at 7.00% per annum.

● During the years ended June 30, ~~2022~~2023 and ~~2021~~2022, Chaya Hendrick, our CEO deferred $15,833 and $15,833 in annual salary, respectively. As of June 30, ~~2022~~2023 and ~~2021~~2022, respectively, the Company has accrued the amounts of $~~753~~769,~~475~~309 and $~~737~~753,~~642~~475 as deferred salary for the difference between Chaya Hendrick’s contractual annual salary and the amounts actually paid. These amounts include previously deferred salary prior to the years ended June 30, ~~2022~~2023 and ~~2021~~2022.

●

On September 30, 2015, we entered into an Addendum to the then existing employment agreement of Chaya Hendrick, pursuant to which in consideration for the issuance of 200,000 shares of the Company’s Series B Convertible Preferred Stock, Chaya Hendrick granted the us the first right to purchase or license any patents (the “Patent Option”) relating to “Smartcards” which the Hendrick (i) shall apply for with the relevant patent authorities during the term of the employment agreement, and (ii) are currently applied for with the relevant patent authorities or pending as of the date of the employment agreement. In exchange for the Patent Option the Company agreed, during the term of the such employment agreement, to pay for any fees and/or expenses related to the application for the such patent rights with the relevant patent authorities, including, but not limited to, legal or filing fees. If, upon our receipt of notice of any patent rights in writing; we and Hendrick fail to successfully negotiate and execute a purchase or license agreement as it relates to such patent rights within 60 calendar days of such receipt, Hendrick shall be permitted to retain or transfer such patent rights to a third party without any subsequent notice to us.

● On September 11, 2017, we entered into a licensing a royalty agreement with Chaya Hendrick, our founder and CEO, whereby we received a license to certain patents related to our technologies until the expiration of such patents in exchange for the following: (i) the issuance to Chaya Hendrick of 200,000 Series B Convertible Preferred Shares, (ii) the payment of 5% of gross revenues derived from the sale of products derived from the patents in the future, and (iii) annual payments beginning at $50,000 per annum, increased by 100% of each previous year (offset against 5% gross revenue royalty payments) for the duration of the term of the agreement. The agreement continues until (i) the terms of the licensed patents expire, (ii) we terminate the agreement with notice to Chaya Hendrick, or (iii) Chaya Hendrick terminates the agreement pursuant to a material breach of our duties or payments contained thereunder. As of June 30, ~~2022~~2023, we had issued the 200,000 shares of Series B Convertible Preferred Stock as required by the license agreement, and Ms. Hendrick had waived the right to annual payments through June 30, ~~2022~~2023.

3335

Item 14.

Principal Accounting Fees and Services

Type of Fees	Year end June 30, ~~2022~~2023		Year end June 30, ~~2021~~2022
Audit Fees		28,116		26,000
Robert Boyle, CPA	$	26,000	$	23,000
Audit Related Fees
Tax Fees		—-		—-
All Other Fees	$	—-		—-
Total Fees	$	2628,~~000~~116	$	2326,000

Policy on Pre-Approval of Audit and Permissible Non-audit Services of Independent Auditors

Consistent with the SEC policies regarding auditor independence, our Board of Directors has responsibility for appointing, setting compensation and overseeing the work of the independent auditor. In recognition of this responsibility, our Board of Directors has established a policy to pre-approve all audit and permissible non-audit services provided by the independent auditor.

Prior to engagement of the independent auditor for the next year’s audit, management will submit an aggregate of services expected to be rendered during that year for each of the following four categories of services to the Board of Directors for approval.

Audit services include audit work performed in the preparation of financial statements, as well as work that generally only the independent auditor can reasonably be expected to provide, including comfort letters, statutory audits, and attest services and consultation regarding financial accounting and/or reporting standards.

Audit-Related services are for assurance and related services that are traditionally performed by the independent auditor, including due diligence related to mergers and acquisitions, employee benefit plan audits, and special procedures required to meet certain regulatory requirements.

Tax services include all services performed by the independent auditor’s tax personnel except those services specifically related to the audit of the financial statements, and includes fees in the areas of tax compliance, tax planning, and tax advice.

Other Fees are those associated with services not captured in the other categories.

3436

PART IV

Item 15.

Exhibits, Financial Statements Schedules

Financial Statements: See “Index to Financial Statements” in Part II, Item 8 of this Form 10-K.

Exhibits: The exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Form 10-K.

Certain of the agreements filed as exhibits to this Form 10-K contain representations and warranties by the parties to the agreements that have been made solely for the benefit of the parties to the agreement. These representations and warranties:

●

may have been qualified by disclosures that were made to the other parties in connection with the negotiation of the agreements, which disclosures are not necessarily reflected in the agreements;

●

may apply standards of materiality that differ from those of a reasonable investor;

●

and were made only as of specified dates contained in the agreements and are subject to later developments.

Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time, and investors should not rely on them as statements of fact.

3537

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SMARTMETRIC, INC.
Date: September 15, 2022	By:	/s/ Chaya Hendrick
Date: October 13, 2023	By:	/s/ Chaya Hendrick
		Chaya Hendrick
		President, Chief Executive Officer and Chairman (Principal Executive Officer)
		President, Chief Executive Officer, and Chairman (Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Name	Title	Date
/s/ Chaya Hendrick	Chief Executive Officer and Director	~~September~~October 1513, ~~2022~~2023
Chaya Hendrick	(~~principal~~Principal executive officer)
/s/ Jay Needelman	Chief Financial Officer	~~September~~October 1513, ~~2022~~2023
Jay Needelman	(~~principal~~Principal financial and accounting officer) and Director
/s/ Elizabeth Ryba	Director	~~September~~October 1513, ~~2022~~2023

3638

SMARTMETRIC, INC. AND SUBSIDIARY

CONSOLIDATED FINANCIAL STATEMENTS

YEARS ENDED JUNE 30, ~~2021~~2023 AND ~~2020~~2022

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM		F-2
CONSOLIDATED BALANCE SHEETS FOR THE YEARS ENDED JUNE 30, 2022 AND 2021		F-3
CONSOLIDATED BALANCE SHEETS FOR THE YEARS ENDED JUNE 30, 2023 AND 2022		F-3
CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED JUNE 30, 2022 AND 2021		F-4
CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED JUNE 30, 2023 AND 2022		F-4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT FOR THE YEARS ENDED JUNE 30, 2022 AND 2021		F-5
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT FOR THE YEARS ENDED JUNE 30, 2023 AND 2022		F-5
CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED JUNE 30, 2022 AND 2021		F-6
CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED JUNE 30, 2023 AND 2022		F-6
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS		F-7

F-1

A close up of a logo

Description automatically generated

Boyle CPA, LLC

Certified Public Accountants & Consultants

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the ~~Shareholders~~Stockholders and Board of Directors

~~Board of Directors of~~ Smartmetric, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance ~~sheet~~sheets of Smartmetric, Inc. (the “Company”) as of June 30, 2023, and June 30, 2022, and the related consolidated statements of operations, changes in stockholders’ (deficit), and cash flows for each of the ~~year~~ years then ended June 30, 2023, and June 30, 2022, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2023, and June 30, 2022, and the results of its operations and its cash flows for each of the ~~year~~years ended June 30, 2023, and June 30, 2022, in conformity with accounting principles generally accepted in the United States of America.

Substantial ~~Doubt~~ ~~About~~doubt about the Company’s ~~Ability~~ability to ~~Continue~~continue as a Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has ~~sustained~~negative ~~recurring~~working ~~losses~~capital and has an accumulated deficit as of June 30, ~~2022~~ 2023. These factors raise substantial doubt about its ability to continue as a going concern ~~for one year from the issuance of these financial statements~~. Management’s plans are also described in Note 1. The financial statements do not include adjustments that might result from the outcome of this uncertainty.

Basis of for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our ~~audit~~audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our ~~audit~~audits in accordance with standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the ~~audit~~audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to fraud or error. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our ~~audit~~audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our ~~audit~~ audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our ~~audit~~audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our ~~audit~~audits ~~provides~~provide a reasonable basis for our opinion.

Critical Audit Matters

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

/s/ ~~Boyle~~ Victor Mokuolu, CPA PLLC PCAOB ID: 6771 We have served as the Company’s auditor since 2022. Houston, ~~LLC~~Texas October 13, 2023

We have served as the Company’s auditor since 2021

Red Bank, NJ September 15, 2022

6285

331 Newman Springs Road		P (732) 784-1582
Building 1, 4th Floor, Suite 143		F (732) 510-0665

Red Bank, NJ 0770

F-2

SMARTMETRIC, INC. AND SUBSIDIARY

Consolidated Balance ~~Sheet~~Sheets

(Audited)


	June 30,			June 30,
	2023			2022
Assets
Current assets:
Cash	$	20,012		$	126,791
Prepaid expenses and other current assets		8,667			13,720

Total current assets		28,679			140,511

Non-current assets
Patent costs (net of amortization)		33,750			-

Total assets	$	62,428		$	140,511

Liabilities and Stockholders’ Deficit
Current liabilities:
Accounts payable and accrued expenses	$	1,233,488		$	1,052,553
Liability for stock to be issued		3,080			115,790
Deferred Officer’s salary		769,309			753,475
Related party interest payable		305,949			253,898
Dividends payable		1,858			1,858
Due to shareholders		52,927			52,927
Covid19 SBA loan		-			20,832
Convertible note payable, net of discount		400,660			0
Derivative liability		-			120,996
Convertible interest payable		22,200			7,249
Interest payable		-			2,625
Shareholder loan		13,814			-

Total current liabilities		2,803,284			2,382,203

Total Liabilities		2,803,284			2,382,203

Commitments and contingencies (See note 4)
Series C mandatory redeemable convertible preferred stock, net of discount, authorized 1,000,000 shares, 17,300 and 65,425 shares issued and outstanding, respectively		15,728			59,478

Stockholders’ deficit:
Class B Preferred stock, $.001 par value; 5,000,000 shares authorized, 610,000 and 610,000 shares issued and outstanding		610			610
Class A Preferred stock, $.001 par value; 50,000,000 shares authorized 0 and 0 shares issued and outstanding		-			-
Common stock, $.001 par value; 2,400,000,000 shares authorized, 2,222,951,485 and 647,886,336 shares issued and outstanding, respectively		2,222,952			647,886
Additional paid-in capital		26,451,292			27,546,376
Accumulated deficit		(31,431,438	)		(30,496,042	)

Total stockholders’ deficit		(2,756,583	)		(2,301,170	)

Total liabilities and stockholders’ deficit	$	62,428		$	140,511

	June 30,			June 30,
	2022			2021
Assets
Current assets:
Cash	$	126,791		$	10,325
Prepaid expenses and other current assets		13,720			5,000
Total current assets		140,511			15,325
Non-current assets
Deferred financing costs		35,000			35,000
Total assets	$	175,511		$	50,325
Liabilities and Stockholders’ Deficit
Current liabilities:
Accounts payable and accrued expenses	$	1,052,553		$	1,073,786
Liability for stock to be issued		115,790			127,321
Deferred Officer’s salary		753,475			737,642
Related party interest payable		253,898			201,846
Dividends payable		1,858			2,442
Due to shareholders		52,927			41,343
Covid19 SBA loan		20,832			41,664
Convertible note payable, net of discount		35,000			35,000
Derivative liability		155,973			45,524
Convertible interest payable		7,249			3,801
Interest payable		2,625			875
Total current liabilities		2,417,203			2,311,244
Commitments and contingencies (See note 4)
Series C mandatory redeemable convertible preferred stock, net of discount, authorized 1000,000 shares, 146,084 and 196,083 shares issued and outstanding, respectively		59,478			196,083
Stockholders’ deficit:
Class B Preferred stock, $.001 par value; 5,000,000 shares authorized, 610,000 and 610,000 shares issued and outstanding		610			610
Class A Preferred stock, $.001 par value; 50,000,000 shares authorized 0 and 0 shares issued and outstanding		-			-
Common stock, $.001 par value; 2,400,000,000 shares authorized, 647,886,336 and 446,385,628 shares issued and outstanding, respectively		647,886			446,386
Additional paid-in capital		27,546,376			25,955,367
Accumulated deficit		(30,496,042	)		(28,859,365	)
Total stockholders’ deficit		(2,301,170	)		(2,457,002	)
Total liabilities and stockholders’ deficit	$	175,511		$	50,325

See notes to consolidated financial statements.

F-3

SMARTMETRIC, INC. AND SUBSIDIARY

Consolidated Statements Ofof Operations

	Year Ended June 30,			Year Ended June 30,
	Year Ended June 30, 2023			Year Ended June 30, 2022
	2022			2021
Revenues	$	-		$	-
Expenses:
Officer’s salary		190,000			190,000
Other general and administrative		814,886			555,480
Advertising costs		207,935			172,047
Research and development		128,616			76,344
Legal and professional fees		139,936			346,603
Total operating expenses		1,133,502			821,824
General and administrative expenses		145,999			280,542
Loss from operations before income taxes		(1,133,502	)		(821,824	)
Amortization expense		1,166			0
Interest & Financing Expense		(71,254	)		(59,914	)
Research and development		125,867			128,616
Gain on PPP loan forgiveness		20,832			-
Total operating expenses		810,903			1,117,808
Gain (loss) on change in derivatives		(468,447	)		(42,990	)
Loss from operations		(810,903	)		(1,117,808	)
Nonoperating Income (Expense)		(518,869	)		(102,904	)
Other Income (Expenses)
Net loss		(1,652,371	)		(924,728	)
Interest & Financing Expense		(127,800	)		(71,254	)
Preferred stock dividends		(7,880	)		(163,575	)
Gain on PPP loan forgiveness		0			20,832
Net loss available for common stockholders	$	(1,687,348	)	$	(1,088,303	)
Gain (loss) on conversions of debt to equity					(468,447	)
Other income (expenses)		3,307
Net loss		(935,396	)		(1,636,677	)
Preferred stock dividends					-
Net loss available for common stockholders	$	(935,396	)	$	(1,636,677	)
Net loss per share, basic and diluted	$	(0.00	)	$	(0.00	)
Weighted average number of common shares outstanding, basic and diluted		~~549~~710,~~174~~803,~~463~~569			~~413~~549,~~974~~174,~~288~~463

See notes to consolidated financial statements.

F-4

SMARTMETRIC, INC. AND SUBSIDIARY

Consolidated Statements of Changes Inin Stockholders’ (Deficit)

(Audited)


	Common Stock				Preferred Stock B				Additional Paid-In			Accumulated			Stockholders’
	Shares		Par Value		Shares		Par Value		Capital			Deficit			Deficiency
Balance June 30, 2021		446,385,628		446,386		610,000		610		25,955,367			(28,859,365	)		(2,457,002	)
Shares issued of common stock and warrants for cash		80,040,996		80,041						850,661						930,702
Shares converted from Preferred C shares to common		76,954,447		76,955						299,546						376,501
Common shares issued for services		19,505,265		19,504						90,802						110,306
Common shares issued for finders fee		25,000,000		25,000						350,000						375,000
Net loss for period								-					(1,636,677	)		(1,636,677	)
Balance June 30, 2022		647,886,336		647,886		610,000		610		27,546,376			(30,496,043	)		(2,301,170	)

Shares issued of common stock and warrants for cash		271,525,383		271,525						(8,295	)					263,230
Shares issued against warrants		244,803,545		244,804						(244,804	)					-
Shares converted from Preferred C shares to common		14,335,488		14,335						29,415						43,750
Shares issued against Liability		153,992,825		153,993						(1,217,945	)					(1,063,951	)
Common shares issued for services		22,750,000		22,750						4,500						27,250
Common shares issued for equity funding conversions		867,657,908		867,658						342,045						1,209,704
Net loss for period								-					(935,396	)		(935,396	)
Balance June 30, 2023		2,222,951,485		2,222,951		610,000		610		26,451,292			(31,431,439	)		(2,756,583	)

	Preferred Series C								Additional Paid In		Accumulated
	Stock				Common Stock				Capital		Deficit			Total
Balance June 30, 2020		610,000	$	610		379,523,000	$	379,523	$	25,429,261	$	(27,771,062	)	$	(1,961,668	)
Shares issued for services		-		-		3,145,440		3,145		15,780		-			18,925
Shares issued of common stock and warrants for cash		-		-		32,500,000		32,500		130,000		-			162,500
Shares converted from Preferred C to common		-		-		31,217,188		31,218		172,149		-			203,367
Valuation of Preferred C and derivative liability		-		-		-		-		208,177		-			208,177
Series C dividends		-		-		-		-		-		(163,575	)		(163,575	)
Net loss for period		-		-		-		-		-		(924,728	)		(924,728	)
Balance June 30, 2021		610,000	$	610		446,385,628	$	446,386	$	25,955,367	$	(28,859,365	)	$	(2,457,002	)
Shares issued of common stock for warrants and cash						80,040,996		80,041		850,661					930,702
Preferred C shares Converted to Common						76,954,447		76,955		299,546					376,501
Common shares issued for services						19,505,265		19,504		90,802					110,306
Common shares issued for finders fees						25,000,000		25,000		350,000					375,000
Series C Preferred Dividends												15,694			15,694
Net loss for period				-								(1,652,371	)		(1,652,371	)
Balance June 30, 2022		610,000	$	610		647,886,336	$	647,886	$	27,546,376	$	(30,496,042	)	$	(2,301,170	)

See notes to consolidated financial statements.

F-5

SMARTMETRIC, INC. AND SUBSIDIARY

Consolidated Statements Ofof Cash Flows

	Year Ended June 30, 2022			Year Ended June 30, 2021
	Year Ended June 30, 2023			Year Ended June 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(1935,~~687,348~~396	)	$	(~~924~~1,~~728~~636,678	)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock issued and issuable for services		485,306			18,926
Amortization		1,166
Non cash financing expense					49,322
Non cash activities:
Gain (loss) on fair value of derivative liability		110,449			112,565
Common stock issued and issuable for services		27,250			485,306
Gain on PPP loan forgiveness		(20,832	)		-
Gain (loss) on fair value of derivative liability					75,472
Amortization of debt discount		~~30,000~~-			230,~~873~~000
Gain on PPP forgiveness		(20,832	)
Changes in assets and liabilities
Increase (Decrease) in prepaid expenses and other current assets		(85,~~720~~053	)		2(8,~~017~~720	)
Increase in accounts payable and accrued expenses		~~(21~~180,~~233~~935	)		~~157~~(21,~~058~~233	)
(Decrease) in deferred officer salary		15,833			~~(22~~15,~~306~~833	)
Increase in Due to shareholder		-13,814			-
Increase in Convertible interest payable		114,~~750~~951			31,~~801~~750
Increase in accrued interest payable		52,052			52,365
Increase in interest payable		(2,625	)		3,448
Net cash used in operating activities		(1,042,743	)		(548,107	)
Decrease in Note Payable		400,660			-
Increase in related party interest payable		52,051			52,052
Net cash used in operating activities		(247,140	)		(1,002,770	)
CASH FLOWS FROM INVESTING ACTIVITIES
Patent Cost		(34,916	)
Net cash used in investing activities		(34,916	)
CASH FLOWS FROM FINANCING ACTIVITIES
Loans from related parties		~~3,297~~			-11,584
Proceeds from sale of common stock		~~985~~263,~~482~~230			~~240~~966,~~698~~784
Proceeds from AJB Note		270,000			(19,475	)
Proceeds from conversion of debt to equity		102,003			-
Proceeds from sale of Series C Preferred stock		~~195,000~~-			~~245~~195,000
Repayment of AJB note		(302,717	)		-
Conversion of Series C Preferred stock		43,750
Change in dividends payable		~~8,147~~-			-(584	)
Proceeds from PPP loan		-			20,832
Change in derivative Liability		(120,996	)
Net cash provided by financing activities		1,159,209			487,055
Repayment of AJB Note		-			(32,717	)
NET INCREASE (DECREASE) IN CASH		116,466			(61,052	)
Net cash provided by financing activities		287,987			1,140,067
CASH BEGINNING OF PERIOD		10,325			71,377
Non cash activities					-
END OF PERIOD		126,791			10,325
Change in stock liability
Non-cash investing and financing activities	$	371,565		$	66,000
Non-cash activities		-			590,778
Conversion of 408,725 & 72,600 Preferred C Shares into 59,420,060 and 21,482,136 shares of common stock
NET INCREASE (DECREASE) IN CASH		5,931			137,297
CASH PAID DURING THE PERIOD FOR:
CASH BEGINNING OF PERIOD		126,791			10,325
Income taxes	$	-		$	-
END OF PERIOD		20,012			126,791
Interest	$	-		$	-

See notes to consolidated financial statements.

F-6

SMARTMETRIC, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 -

ORGANIZATION AND BASIS OF PRESENTATION

SmartMetric, Inc. (the “Company” or “SmartMetric”) was incorporated in the State of Nevada on December 18, 2002. SmartMetric’s main product is a fingerprint sensor-activated card with a finger sensor onboard the card and a built-in rechargeable battery for portable biometric identification. This card may be referred to as a biometric card or the SmartMetric Biometric Datacard. SmartMetric has completed development of its card along with pre-mass manufacturing cards but has not yet begun to mass manufacture the biometric fingerprint activated cards.

Basis of Presentation

The ~~financial~~ ~~statements present the balance sheets, statements of operations, stockholder’s equity (deficit) and cash flows of the Company. The~~ financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America.

The Company has adopted June 30 as its fiscal year end.

Going Concern

As shown in the accompanying ~~condensed~~ consolidated financial statements the Company has sustained recurring losses available to common shareholders of $1935,~~687,348~~ 396 and $~~924~~1,~~728~~636,677 for the period ended June 30, ~~2022~~2023 and ~~2021~~2022, respectively, and has an accumulated deficit of $31,431,438 at June 30, 2023 and $30,496,042 at June 30, 2022.

These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date of this filing. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The COVID-19 has had an impact on SmartMetric’s final card production. While the delays are due to supply line disruption, the Company is confident that these delays will be short-lived based on advice from our manufacturing partners, manufacturing alternatives and alternative supply lines that are being put into place by the Company.

Management believes that the Company’s capital requirements will depend on many factors. These factors include product marketing and distribution. The management plans include equity sales and borrowing in order to fund the operations. The Company plans to continue its relationship with Geneva Roth Remark in order to raise capital through means other than private placement stock sales.

There are no assurances that the Company will be able to achieve the level of revenues adequate to generate sufficient cash flow from operations to support the Company’s working capital requirements. To the extent that funds generated are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available, the Company may not continue its operations.

On March 5, 2020, the Company entered into an agreement with GHS Investments, LLC whereas the investor agrees to invest up to four million dollar ($4,000,000) over the 36 months immediately subsequent to the effective date of the agreement.

In December 2019, an outbreak of a novel strain of coronavirus originated in Wuhan, China (“COVID-19”) and has since spread worldwide, including to the Unites States, posing public health risks that have reached pandemic proportions (the “COVID-19 Pandemic”). The COVID-19 Pandemic poses a threat to the health and economic wellbeing of our employees, customers and vendors. Like most businesses world-wide, the COVID-19 Pandemic has impacted the Company financially; delaying the beginning of production.

F-7

SMARTMETRIC, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 2 -

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Recent Accounting Pronouncements

The Company ~~does~~has ~~not~~reviewed ~~expect~~all ~~the~~new ~~adoption of recently issued~~ accounting pronouncements toand ~~have~~has aconcluded ~~significant~~that ~~impact~~there onwill ~~the~~be ~~Company’s results~~no ofnew ~~operations,~~pronouncements ~~financial~~to ~~position or cash flow except as noted below~~adopt.

In February 2016, the FASB issued authoritative guidance ASC 842, “Leases.” This guidance requires lessees to recognize most leases on the balance sheet by recording a right-of-use asset and a lease liability. The Company has made the decision to adopt this guidance early, and it was adopted by the Company as of March 1, 2019. Based on the completed analysis, the Company has determined that the adjustment did not have a material impact on the financial statements.

In June 2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity—Equity-Based Payments to Non-Employees. This guidance was adopted by the Company as of March 1, 2019. Based on the completed analysis, the Company has determined the adjustment did not have a material impact on the financial statements.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, SmartMetric Australia Pty. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation.

Fair Value of Financial Instruments

The carrying amounts reflected in the balance sheets for cash, accounts payable and related party payables approximate the respective fair values due to the short maturities of these items.

As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

The three levels of the fair value hierarchy are described below:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

The Company at present does not have any Level 2 or Level 3 fair value instruments.

F-8

SMARTMETRIC, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 2 -

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to income taxes and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.

Cash

The Company considers all highly liquid debt instruments and other short-term investments with an initial maturity of three months or less to be cash equivalents. Any amounts of cash in financial institutions which exceed FDIC insured limits exposes the Company to cash concentration risk. The Company had no cash equivalents at June 30, ~~2022~~2023 and ~~2021~~2022.

Research and Development

Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation, and consulting costs.

Revenue Recognition

The Company has not recognized revenues to date. Therefore, the Company has not yet adopted a revenue recognition policy.

Reclassifications

Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.

Uncertainty in Income Taxes

GAAP requires the recognition and measurement of uncertain income tax positions using a “more-likely-than-not” approach. Management evaluates Company tax positions on an annual basis and has determined that as of June 30, ~~2022~~2023 and ~~2021~~2022, no accrual for uncertain income tax positions is necessary.

Loss Per Share of Common Stock

In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of June 30, ~~2022~~2023 and ~~2021~~2022, 4516,~~997~~935,~~852~~342 and ~~124~~45,~~888~~997,~~519~~852 dilutive shares were excluded from the calculation of diluted loss per common share, with all dilutive shares being Common stock warrants at June 30, ~~2022~~ 2023 and ~~2021~~2022.

F-9

SMARTMETRIC, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 3 -

PREPAID EXPENSES

Prepaid expenses were $8,667 and $13,720 at June 30, 2023 and 2022. All prepaid expenses consist of OTC market fees.

NOTE 4 -

COMMITMENTS

Lease Agreement

The Company’s main office is in Las Vegas, Nevada. Rent expense under all leases for the years ended June 30, ~~2022~~2023 and ~~2021~~ 2022 was $7,~~613~~387 and $57,~~238~~613 respectively. The Company maintains only one office. This office is in Las Vegas, NV and is a month-to-month lease.

Related Party Transactions

The Company’s Chief Executive Officer has made cash advances to the Company with an aggregate amount due of $313,~~297~~814 and $0 as of June 30, ~~2022~~2023 and ~~2021~~2022, respectively. These advances bear interest at 7~~.00~~% per annum.

As of June 30, ~~2022~~2023 and June 30, ~~2021~~2022, the Company has accrued the amounts of $~~753~~769,~~475~~309 and $~~737~~753,~~642~~475, respectively, as deferred Officer’s salary for the difference between the president’s annual salary and the amounts paid.

As a result of these shareholder loans and deferred officer salary, the Company has accrued a balance of $~~253~~305,~~898~~949 and $~~201~~253,~~846~~898 as interest payable as of June 30, ~~2022~~2023 and ~~2021~~2022.

On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, 200,000 shares of Series B Convertible Preferred Stock, we agreed to pay a royalty equal to 5% of gross revenues derived from products sold related to the patents, and we agreed to make certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares. As of June 30, ~~2022~~2023, we had issued the 200,000 shares of Series B Convertible Preferred Stock, and Ms. Hendrick had waived the right to annual payments through June 30, ~~2022~~ 2023.

Our CEO maintains an employment agreement that stipulates a $190,000 annual salary. This agreement is in effect until mutual agreement between its CEO and the Company to terminate.

NOTE 5 -

DEBT

~~In March~~The ofCompany ~~2020,~~analyzed the ~~Company~~conversion ~~applied~~option for ~~the~~derivative ~~SBA~~accounting ~~PPP~~consideration ~~government~~under ~~loan~~ASC 815, “Derivatives and ~~was~~Hedging,” ~~approved.~~and Ondetermined ~~April 17,2020,~~that the ~~Company~~convertible ~~received $20,832~~notes should be classified as ~~proceeds~~a ~~from~~liability ~~this~~since ~~loan~~the conversion option becomes effective at default resulting in there being no explicit limit to the number of shares to be delivered upon settlement of the above conversion options. The Company ~~successfully~~has ~~applied~~recorded tothe ~~have~~embedded ~~this~~derivative ~~loan~~liability ~~forgiven.~~at its’ fair value utilizing the Black-Scholes Merton option pricing model, as follows:

In March of 2021, the Company applied for the SBA PPP government loan and was approved. On March 29, 2021, the Company received $20,832 as proceeds from this loan. The Company successfully applied to have this loan forgiven.

Level 1

Level 2

Level 3

Total

Derivative liability

On March 5, 2020, the Company issued a $35,000 10% convertible note. The note was due on December 5, 2020 and is convertible at a rate of $0.0175 per share which resulted in a discount from the beneficial conversion feature totaling $5,000. During the year ended June 30, 2020, $2,127 of the debt discount was amortized. During the year ended June 30, 2021, the remaining $2,873 of the debt discount was amortized. As of June 30, the Company was in negotiations to extinguish this debt.

F-10

SMARTMETRIC, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 5 - DEBT (CONTINUED)

The 10% convertible note is currently in default. Upon default, the fixed conversion price became a Variable Conversion Price, which is 70% multiplied by the lowest trading price for the Company’s common stock during the 20 trading day period ending on the latest complete trading day prior to the conversion date.

The Company analyzed the conversion option for derivative accounting consideration under ASC 815, “Derivatives and Hedging,” and determined that the convertible notes should be classified as a liability since the conversion option becomes effective at default resulting in there being no explicit limit to the number of shares to be delivered upon settlement of the above conversion options. The Company has recorded the embedded derivative liability at its’ fair value utilizing the Black-Scholes Merton option pricing model, as follows:

Schedule of Derivative Liabilities
	Level 1		Level 2		Level 3		Total
Derivative liability	$	-	$	-	$	45,524	$	45,524

NOTE 6 -

STOCKHOLDERS’ DEFICIT

Preferred Stock

As of June 30, ~~2022~~2023, the Company has 5,000,000 shares of Series B preferred stock, par value $0.001, authorized and 610,000 shares issued and outstanding.

Each share of Series B Convertible Preferred Stock has a par value of $0.001, and a stated value equal to $5.00 (“Stated Value”). Holders of the Series B Convertible Preferred Stock are entitled to receive dividends or other distributions with the holders of the common stock of the Company on an as converted basis when, as, and if declared by the directors of the Company. Holders of the Series B Convertible Preferred Stock are entitled to convert all or any one (1) share of the Series B Convertible Preferred Stock into fifty (50) shares of common stock.

Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary (“liquidation”), holders of the Series B Convertible Preferred Stock are entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, pro rata with the holders of the common stock.

The Company issued 200,000 Series B preferred shares upon its inception in 2004.

In October 2015, the Company issued 200,000 Series B preferred shares.

On September 11, 2017, the Company issued an additional 210,000 shares of Series B preferred shares to its CEO, Chaya Hendrick, in consideration for grant of exclusive rights to the licensed patent.

As of June 30, 2023, the Company has 50,000,000 shares of Class A ~~Common~~preferred ~~Stock~~stock, par value $0.001, authorized and no shares issued and outstanding.

~~As of~~Common ~~June 30,~~Stock ~~2022, the Company has 50,000,000 shares of Class A common stock, par value $0.001, authorized~~ and ~~no shares issued and outstanding.~~Warrants

● During the three ~~month~~months ~~period~~ended ~~ending~~September ~~December 31~~30, ~~2019~~2022, the Company ~~increased~~issued ~~its~~257,962,697 ~~total~~shares ~~number~~of common stock, of which 9,750,000 were issued from stock payable, 14,385,488 were converted from 48,125 shares of ~~authorized~~Preferred ~~capital~~C ~~stock to~~shares, ~~600~~22,~~000~~250,000 shares were issued for advertising and promotional services and 221,327,209 ~~par~~shares ~~value~~were ~~$0.001~~issued ~~per~~in ~~share~~conjunction with securities purchase agreements for net proceeds of $330,700.

●

During the three months ended September 30, 2022, the Company sold 0 shares of common stock for net proceeds of $0. The Company issued 4,000,000 shares representing $20,000.

●

During the three months ended December 31, 2022, the Company issued 582,059,999 shares of common stock, of which 4,000,000 were issued for cash and 578,059,999 shares were issued in conjunction with securities purchase agreements.

●

During the three months ended December 31, 2022, the Company sold 0 shares of common stock for net proceeds of $0.

●

During the three months ended March 31, 2023, the Company sold 11,000,000 shares of common stock for net proceeds of $60,000.

F-11

SMARTMETRIC, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6 -

STOCKHOLDERS’ DEFICIT (CONTINUED)

~~Common Stock~~● During the three months that ended March 31, 2023, the Company issued 155,786,846 shares of common stock, of which 11,000,000 were issued for cash, 500,000 shares were issued for services and ~~Warrants~~144,286,846 shares were issued in conjunction with securities purchase agreements.

● During the three months ended ~~September~~June 30, ~~2019~~2023, the Company sold for cash 6213,~~337~~333,~~500~~328 shares of common stock ~~and warrants to purchase: (i) 6,337,500 shares at prices ranging from $0.10 per share to $0.25 per share~~ for net proceeds of $~~133~~116,~~495~~940. The warrants expire at various times through September 17, 2021. None of these shares were issued during the quarter ended September 30, 2019, with all 6,337,500 shares being recorded as stock payable.

	●	During the three months ended December 31, 2019, the Company sold for cash 40,675,000 shares of common stock and warrants to purchase: (i) 825,000 shares at prices ranging from $0.20 per share to $0.25 per share for net proceeds of $214,510. The warrants expire at various times through November 1, 2021. None of these shares were issued during the quarter ended December 31, 2019, with all 40,675,000 shares being recorded as stock payable. There were 36,300 Preferred C shares converted to 2,370,696 Common shares for the three month period ending December 31, 2019, see Note 6.
	●	During the three months ended March 31, 2020, the Company sold for cash 9,550,000 shares of common stock and warrants to purchase: (i) 3,500,000 shares at prices ranging from $0.05 per share to $1.00 per share for net proceeds of $66,500. The warrants expire at various times through March 12, 2022. None of these shares were issued during the quarter ended March 31, 2020, with all 9,550,000 shares being recorded as stock payable.

●

During the three months that ended June 30, 2023, the Company issued 579,255,607 shares of common stock, of which 189,833,325 were issued for cash and 389,422,282 shares were issued in conjunction with securities purchase agreements.

● During the three months ended ~~June~~September 30, ~~2020~~2022, the Company ~~sold~~issued ~~for cash 40~~257,~~000~~962,~~000~~697 shares of common stock, ~~and~~of ~~warrants~~which ~~to purchase: (i) 12~~9,~~000~~750,000 ~~shares~~were atissued ~~prices ranging~~ from ~~$0.10~~stock ~~per~~payable, ~~share~~14,385,488 towere ~~$0.20~~converted ~~per~~from ~~share~~48,125 ~~for~~shares ~~net~~of ~~proceeds~~Preferred ofstock, ~~$200~~22,~~905.~~250,000 ~~The~~shares ~~warrants~~were ~~expire~~issued atfor ~~various~~advertising ~~times~~and ~~through~~promotional ~~June~~services ~~12,~~and ~~2021. 31~~221,~~000~~327,~~000~~209 ~~of these~~ shares were issued ~~during~~in ~~the~~conjunction ~~quarter ended June 30, 2020,~~ with ~~9,000,000~~securities ~~shares~~purchase ~~being~~agreements ~~recorded~~for asnet ~~stock~~proceeds ~~payable~~of $291,410.

● During the three months ended September 30, ~~2020~~2022, the Company sold ~~for~~0 ~~cash 17,500,000~~ shares of common stock ~~and warrants to purchase: (i) 17,500,000 shares at prices ranging from $0.05 per share to $0.10 per share and (ii) 14,500,000 shares at prices ranging from $0.10 to $0.20~~ for net proceeds of $~~77,409~~0. The warrants expire at various times through September 21, 2022. All 17,500,000 of these shares were issued during the quarter ended December 31, 2020, with all 17,500,000 shares being recorded as stock payable. The Company issued 6,032,260 shares. Of these shares, 585,000 were issues for consulting services and 5,447,260 were converted from Preferred shares.

● During the three months ended December 31, ~~2020~~2022, the Company ~~sold~~issued 16582,~~500~~059,~~000~~999 shares of common stock, ~~for net proceeds~~ of ~~$82,455.~~which ~~With these issuances the company also issued warrants to purchase: (i) 16~~4,~~500,~~000 ~~shares at prices ranging from $0.05 to $0.10 per share and (ii) 16~~,~~500,~~000 ~~shares~~were atissued ~~prices~~for ~~ranging~~cash ~~from $0.10 to $0.20~~ and ~~(iii) 1~~578,~~500~~059,~~000~~999 ~~at a price of $0.30. The warrants expire at various times through December 21, 2022. None of the 16,500,000~~ shares were issued ~~during~~in ~~the~~conjunction ~~quarter~~with ~~ended~~securities ~~December~~purchase ~~31, 2020, and were recognized as stock payable~~agreements.

● During the three months ended December 31, ~~2020~~2022, the Company ~~issued~~sold ~~32,034,876~~0 shares ~~for $75,000,~~ of ~~which~~common ~~15,000,000 were issued from~~ stock ~~payable~~for ~~and~~net ~~16,034,876~~proceeds ~~were~~of ~~converted from 78,100 Preferred shares~~$0.

●Warrants ~~During~~Outstanding the three months ended March 31, 2021, the Company sold 11,000,000 shares of common stock for net proceeds of $59,957. With these issuances the company also issued warrants to purchase: (i) 12,000,000 shares at a price of $0.10 per share and ~~(ii)~~Exercisable ~~12,000,000 shares~~ at ~~a price of $0.20. The warrants expire at various times through February 4~~June 30, ~~2022. None of the 12,000,000 shares were issued during the quarter ended March 31, 2021, and were recognized as stock payable.~~2023:


Range of Exercise Prices	Number of Warrants Outstanding		Weighted- Average Contractual Life Remining in Years		Weighted- Average Exercise Price		Number Exercisable		Weighted- Average Exercise Price
Warrants Outstanding and Exercisable at June 30, 2022:

$0.10 - $0.20		45,997,852		0.519	$	0.18		45,997,852	$	0.519

Warrants Outstanding and Exercisable at June 30, 2023:

$0.10 - $0.20		16,935,352		0.487	$	0.16		16,935,352	$	0.487

F-12

SMARTMETRIC, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6 -

STOCKHOLDERS’ DEFICIT (CONTINUED)

● During the three months ended March 31, 2021, the Company issued 26,769,540 shares, of which 17,000,000 were issued from stock payable, 6,709,100 were converted from 72,600 Preferred shares and 2,560,440 shares were issued for legal services.

● During the three months ended June 30, 2021, the Company sold 3,333,333 shares of common stock for net proceeds of $20,000. With these issuances the company also issued warrants to purchase: (i) 3,333,333 shares at a price of $0.10 per share and (ii) 3,333,333 shares at a price of $0.20. The warrants expire at various times through June 8, 2022. None of the 3,333,333 shares were issued during the quarter ended June 30, 2021, and were recognized as stock payable.

● During the three months ended June 30, 2021, the Company issued 3,025,952 shares, all of which were converted from 36,300 Preferred C shares.

● During the three months ended September 30, 2021, the Company sold 5,500,000 shares of common stock for net proceeds of $27,462. With these issuances the company also issued warrants to purchase: (i) 5,500,000 shares of common stock at a price of $0.10 per share and (ii) 5,500,000 shares of common stock at a price of $0.20 per share. The warrants expire at various times through September 21, 2022. None of the 12,000,000 shares of common stock were issued during the quarter ended September 30, 2021, and were recognized as stock payable.

● During the three months ended September 30, 2021, the Company issued 42,262,958 shares of common stock, of which 8,133,333 were issued from stock payable, 17,534,387 were converted from 116,050 shares of Preferred stock and 4,095,238 shares were issued for legal services and 12,500,000 shares were issued as a finder’s fee.

● As of December 31, 2021, the Company had 539,310,756 shares of common stock issued and outstanding.

● During the three months ended December 31, 2021, the Company sold 8,625,000 shares of common stock for net proceeds of $86,230. With these issuances the Company also issued warrants to purchase: (i) 8,625,000 shares of common stock at a price of $0.70 per share and (ii) 4,312,500 shares of common stock at a price of $1.00 per share. The warrants expire at various times through December 14, 2022. None of the 8,625,000 shares of common stock were issued during the quarter ended December 31, 2021, and were recognized as stock payable.

● During the three months ended December 31, 2021, the Company issued 50,662,170 shares of common stock, of which 11,032,663 shares were issued from stock payable, 19,148,052 were converted from 107,000 shares of Preferred stock, 7,981,445 shares were issued for legal services and 12,500,000 shares were issued as a finder’s fee to AJB Capital.

● During the three months ended March 31, 2022, the Company issued 77,040,836 shares of common stock, of which zero were issued from stock payable, 15,826,550 were converted from 90,750 shares of Preferred stock, 3,714,286 shares were issued for legal services and 57,500,000 shares were issued in conjunction with securities purchase agreements for net proceeds of $783,000.

● During the three months ended March 31, 2022, the Company sold 2,000,000 shares of common stock for net proceeds of $19,980. With these issuances the Company also issued warrants to purchase: (i) 2,000,000 shares of common stock at a price of $0.70 per share and (ii) 1,000,000 shares of common stock at a price of $1.00 per share. The warrants expire at various times through February 9, 2023. None of the 2,000,000 shares of common stock were issued during the quarter ended March 31, 2022, and were recognized as stock payable.

F-13

SMARTMETRIC, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6 - STOCKHOLDERS’ DEFICIT (CONTINUED)

● During the three months ended June 30, 2022, the Company issued 31,534,744 shares of common stock, of which zero were issued from stock payable, 24,445,458 were converted from 76,250 shares of Preferred stock, 3,714,286 shares were issued for legal services and 0 shares were issued in conjunction with securities purchase agreements for net proceeds of $0.

● During the three months ended June 30, 2022, the Company sold 0 shares of common stock for net proceeds of $0.

The following information summarizes the warrants outstanding and exercisable.

Warrants Outstanding and Exercisable at June 30, 2022:

Schedule of share based compensation warrant activity
Range of Exercise Prices	Number of Warrants Outstanding		Weighted- Average Contractual Life Remining in Years		Weighted- Average Exercise Price		Number Exercisable		Weighted- Average Exercise Price
Warrants Outstanding and Exercisable at June 30, 2021:
$0.05 - $1.00		124,888,519		0.623	$	0.18		124,888,519	$	0.623
Warrants Outstanding and Exercisable at June 30, 2022:
$0.10 - $0.20		45,997,852		0.519	$	0.18		45,997,852	$	0.519

Warrant Activity:

As of June 30, ~~2022~~2023 and ~~2021~~2022, the following is a breakdown of the activity:

June 30, 2023:

Schedule of warrant activity
Outstanding - beginning of year	45,997,852
Issued	-
Exercised	-
Expired	(29,062,500	)
Outstanding - end of year	16,935,352

June 30, 2022:

Schedule of warrant activity
Outstanding - beginning of year	124,888,519
Issued	22,937,499
Exercised	—-
Expired	(101,828,166	)
Outstanding - end of year	45,997,852

At June 30, ~~2021:~~ 2023, all of the 16,935,352 warrants are vested, all 16,935,352 warrants expire at various times through December 2023. At June 30, 2022,all 45,997,852 warrants are vested and all 45,997,852 warrants expire at various times through June 2023.

Outstanding - beginning of year	53,280,406
Issued	98,500,000
Exercised	—
Expired	(26,891,887	)
Outstanding - end of year	124,888,519

F-13

At June 30, 2022, all of the 45,997,852 warrants are vested, all 45,997,852 warrants expire at various times through February 2023.

F-14

SMARTMETRIC, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6 -

STOCKHOLDERS’ DEFICIT (CONTINUED)

Equity Financing

On March 5, 2020, the Company entered into an equity financing agreement with GHS Investments, LLC, a Nevada limited liability company (“Investor”). Pursuant to the agreement, the Company agrees the sell to the investor an indeterminate amount of shares of the Company’s common stock, par value $0.001 per share, up to an aggregate price of four million dollars ($4,000,000).

Pursuant to the agreement, the Company is required, to within sixty (60) calendar days upon the date of execution of this agreement, use its best efforts to file with the SEC a registration statement or registration statements (as is necessary) on Form S-1, covering the resale of all of the registrable securities, which registration statement(s) shall state that, in accordance with Rule 416 promulgated under the 1933 Act, such registration statement also covers such indeterminate number of additional shares of Common Stock as may become issuable upon stock splits, stock dividends or similar transactions. Pursuant to this equity financing agreement, the Company filed the Registration S-1 on August 6, 2020.

Following effectiveness of the Registration Statement, the Company shall have the discretion to deliver puts to GHS and GHS will be obligated to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice shall not exceed two hundred percent (200%) of the average daily trading dollar volume of the Company’s Common Stock during the ten (10) trading days preceding the put, so long as such dollar amount does not exceed $500,000. Pursuant to the Equity Financing Agreement, GHS and its affiliates will not be permitted to purchase and the Company may not put shares of the Company’s Common Stock to GHS that would result in GHS’s beneficial ownership, equaling more than 4.99% of the Company’s outstanding Common Stock. The price of each put share shall be equal to eighty percent (80%) of the Market Price (as defined in the Equity Financing Agreement). Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the Registration Statement. The Registration Statement has not been deemed effective as of the date of this filing.

Concurrently with the execution of the equity financing agreement, the company entered into a convertible promissory note, for the principal balance of $35,000. Per the terms of the convertible note agreement, the Company agrees to pay the investor interest at the rate of ten percent (10%) until it is due on December 5, 2020. The holder shall have the right at any time to convert all or any part of the outstanding and unpaid principal and interest at a fixed conversion price of $0.0175. See note 5. The $35,000 has been recognized as deferred financing costs in current assets on the accompanying Consolidated Balance Sheet, and will be charged against the gross proceeds of each put when received. Although the Company has not as of yet put to GHS, the agreement is in effect for three years, through March, 2023, and as the Company does plan to put to GHS, the Company has determined it is proper for the deferred costs to remain for the length of the agreement.

As of June 30, 2022, the Company was in negotiations to have this debt extinguished.

~~F-15~~As of July 2022, this debt was extinguished.

F-14

SMARTMETRIC, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 7 -

MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK

Issuances of Series C Mandatory Redeemable Convertible Preferred Stock

On January 10, 2019, the Board of Directors of the Company adopted a resolution pursuant to the Company’s Certificate of Incorporation, as amended, providing for the designations, preferences and relative, participating, optional and other rights, and the qualifications, limitations, and restrictions, of the Series C Convertible Preferred Stock.

On January 14, 2019, the Company filed a Certificate of Designations for a Series C Convertible Preferred Stock. The authorized number of Series C Convertible Preferred Stock is 1,000,000 shares, par value 0.001. The Series C Preferred Stock will, with respect to dividend rights and rights upon liquidation, winding-up or dissolution, rank: (a) senior with respect to dividends and right of liquidation with the Company’s common stock, (b) junior with respect to dividends and right of liquidation with respect to the Company’s Series B Preferred Stock; and (c) junior with respect to dividends and right of liquidation to all existing indebtedness of the Company. Series C Preferred Stock will carry an annual ten percent (10%) cumulative dividend, compounded daily, payable solely upon redemption, liquidation, or conversion. The Company will have a right, at any time in the period of 180 days from the date of the issuance, at the Company’s option, to redeem all or any portion of the Series C Preferred Stock at prices ranging from 105% to 130%, based on the passage of time.

The number of Series C, mandatory redeemable convertible preferred stock shares issued and outstanding were 6517,~~425~~300 and ~~239~~65,~~025~~425, respectively, for June 30, ~~2022~~2023 and June 30, ~~2021~~2022.

The Holder shall have the right at any time during the period beginning on the date which is six (6) months following the Issuance Date, to convert all or any part of the outstanding Series C Preferred Stock into fully paid and non-assessable shares of Common Stock at the Variable Conversion Price. The “Variable Conversion Price” shall mean 71% multiplied by the Market Price (representing a discount rate of 29%). “Market Price” means the average of the two (2) lowest Trading Prices (as defined here) for the Common Stock during the fifteen (15) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date.

On the date which is eighteen (18) months following the Issuance Date or upon the occurrence of an Event of Default (the “Mandatory Redemption Date”), the Company shall redeem all of the shares of Series C Preferred Stock of the Holder (which have not been previously redeemed or converted). With five (5) days of the Mandatory Redemption Date, the Company shall make payment to each Holder of an amount in cash equal to the total number of shares of Series C Preferred Stock held by such Holder multiplied by the then current Stated Value.

All shares of mandatorily redeemable convertible preferred stock have been presented outside of permanent equity in accordance with ASC 480, Classification and Measurement of Redeemable Securities. The Company accretes the carrying value of its Series C mandatory redeemable convertible preferred stock to its estimate of fair value (i.e., redemption value) at period end.

The carrying value of the Series C mandatory redeemable convertible preferred stock at June 30, ~~2022~~2023 and ~~2021~~2022 was $2315,~~584~~728 and $~~196~~59,~~083~~478, respectively.

The estimated fair value of the Series C, mandatory redeemable convertible preferred stock at June 30, ~~2022~~2023 and ~~2021~~2022 was $2315,~~584~~ 728 and $~~196~~59,~~083~~478, respectively.

The Company recorded preferred stock dividends of $0 and $~~163,575~~0 and accrued dividends payable of $1,858 and $21,~~442~~858 during fiscal year end ~~2022~~2023 and ~~2021~~2022, respectively.

F-1615

SMARTMETRIC, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 8 -

INCOME TAXES

Deferred income taxes are determined using the liability method for the temporary differences between the financial reporting basis and income tax basis of the Company’s assets and liabilities. Deferred income taxes are measured based on the tax rates expected to be in effect when the temporary differences are included in the Company’s tax return. Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases. The Company recognizes interest and penalties related to income tax matters as a component of income tax expense.

At June 30, ~~2022~~2023 and ~~2021~~2022, deferred tax assets consist of the following:

Schedule of deferred tax assets and liabilities
	2022			2021
	2023			2022
Net operating loss carryforward	$	1031,~~965~~431,~~212~~438		$	910,~~789~~965,~~107~~212
Warrant issuances		—-			—-
Deferred officer compensation		~~757~~769,~~011~~309			~~737~~757,~~642~~011
Other		-0-			-0-
Valuation allowance		(1132,~~722~~200,~~223~~747	)		(1011,~~526~~722,~~749~~223	)
Deferred tax assets, net	$	—-		$	—-

At June 30, ~~2022~~2023, the Company had a net operating loss carry-forwards in the amount of approximately $~~30.5~~31,431,438 million available to offset future taxable income through ~~2039~~2040. These amounts may be carried forward indefinitely, subject to the 80% of taxable income limitation rule. The Company established valuation allowances equal to the full amount of the deferred tax assets due to the uncertainty of the utilization of the operating losses in future periods. A reconciliation of the Company’s effective tax rate as a percentage of income before taxes and federal statutory rate for the period ended June 30, ~~2022~~2023 and ~~2021~~2022 is summarized as follows:

Schedule of effective income tax rate reconciliation
	2022			2021
	2023			2022
Tax on income before income tax		21.00	%		21.00	%
Effect of non-temporary differences		(0.01	)%		(0.01	)%
Effect of prior year items		—-	%		—-	%
Effect of temporary differences		—-	%		—-	%
Change in valuation allowance		(1918.1464	)%		(2019.9914	)%
Effective income tax rate reconciliation, percent		0.00	%		0.00	%

The total amount of unrecognized tax benefits can change due to tax examination activities, lapse of applicable statutes of limitations and the recognition and measurement criteria under the guidance related to accounting for uncertainty in income taxes. The Company does not believe any significant increases or decreases will occur within the next twelve months.

The Company files income tax returns in the United States (“U.S.”) federal jurisdiction. Generally, the Company is no longer subject to U.S. federal examinations by tax authorities for fiscal years prior to ~~2018~~2019. The Company does not file in any other jurisdiction and remains open for audit for all tax years as the statute of limitations does not begin until the returns are filed. The Company remains subject to U.S. federal examination for tax years ended ~~2018,~~ 2019, 2020, 2021, 2022 and ~~2022~~2023.

F-1716

SMARTMETRIC, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 9 -

LITIGATION

From time to time we may be a defendant or plaintiff in various legal proceedings arising in the normal course of our business. We know of no material, active, pending or threatened proceeding against us or our subsidiaries, nor are we, or any subsidiary, involved as a plaintiff or defendant in any material proceeding or pending litigation.

NOTE 10 -

SUBSEQUENT EVENTS

In accordance with ASC 855-10, the Company has reviewed its operations subsequent to June 30, ~~2022~~2023 to the date these financial statements were issued.

On July 14 24, ~~2022~~2023, the Company ~~successfully~~issued ~~extinguished~~96,800,000 ~~its~~shares ~~debt~~of common stock to ~~GHS~~an ~~Holdings~~unrelated party for conversion of note payable in the amount of $96,800.

~~Subsequent~~On toJuly ~~June 30~~25, ~~2022~~2023, the Company issued ~~0 Preferred C shares for $0 cash and 186~~20,~~495~~000,~~105~~000 ~~common~~ shares. ~~The~~of ~~Company~~common ~~converted 65,425~~stock ~~preferred~~to ~~shares~~an ~~into~~unrelated ~~9,583,333~~party ~~common~~for ~~shares~~$10,000.

~~F-18~~On September 5, 2023, the Company issued 61,334,886 shares of common stock to an unrelated party for conversion of note payable in a cashless warrant exercise.

On July 25, 2023, the Company issued 100,000 shares of common stock to an unrelated party for $4,000.

F-17

INDEX TO EXHIBITS

		Incorporated by Reference			Filed or
Exhibit Number	Exhibit Description	Form	Exhibit	Filing Date	Furnished Herewith
3.01	Articles of Incorporation of SmartMetric, Inc. filed 12/18/02	SB-2	3.1	9/3/04
3.02	Amendment to Articles of Incorporation dated 12/11/09	8-K	3.1	12/18/09
3.03	Amendment to Articles of Incorporation dated June 8, 2016	10-K	3.5	9/28/16
3.04	Certificate of Designation of Series B Preferred Stock	8-K	3.2	12/18/09
3.05	Amendment to Certificate of Designation of Series B Preferred Stock dated 11/5/14	10-Q	3.1	11/14/14
3.06	Amendment to Certificate of Designation of Series B Preferred Stock dated 6/8/16	10-K	3.4	9/28/16
3.07	Amended and Restated Bylaws of SmartMetric	8-K	3.1	4/26/16
3.08	Series C Preferred Stock Certificate of Designations dated 1/14/19	8-K	3.1	1/18/19
4.01	Common Stock Certificate Specimen				X
4.02	Form of Warrant issued to May 2013 Investor	8-K	4.1	5/28/13
4.03	Form of Warrant issued to investors between 2015 – 2017	10-K	4.03	10/13/17
4.04*	SmartMetric, Inc. 2017 Equity Compensation Plan	10-Q	4.04	11/14/17
4.05*	Form of Option Grant under 2017 Equity Compensation Plan	10-Q	4.05	11/14/17
4.06*	Form of Restricted Stock Grant under 2017 Equity Compensation Plan	10-Q	4.06	11/14/17
4.07*	Form of Restricted Stock Unit Grant under 2017 Equity Compensation Plan	10-Q	4.07	11/14/17
4.08	Convertible Promissory Note dated March 5, 2020 issued by SmartMetric, Inc. in favor of GHS Investments LLC	S-1	4.08	8/6/20
10.01*	Assignment and Assumption Agreement dated 11/12/12 with Applied Cryptography	8-K	10.1	11/16/12
10.02	Subscription Agreement with May 2013 Investor	8-K	10.1	5/28/13
10.03*	Employment Agreement dated July 1, 2012 with Chaya Hendrick and Addendum dated 9/30/15	8-K	10.8	10/5/15
10.05	Form of Securities Purchase Agreement with investors used between 2015 - 2017	10-K	10.05	10/13/17
10.06*	Employment Agreement with Chaya Hendrick dated July 1, 2017	10-K	10.06	10/13/17
10.07*	Issued Patent License and Royalty Agreement dated 9/11/17 with Chaya Hendrick	10-K	10.07	10/13/17

3739

10.06*	Employment Agreement with Chaya Hendrick dated July 1, 2017	10-K	10.06	10/13/17

10.07*	Issued Patent License and Royalty Agreement dated 9/11/17 with Chaya Hendrick	10-K	10.07	10/13/17

10.08*	Jay Needelman Services Agreement	10-K/A	10.01	10/27/17

10.09	Manufacturer’s Representative Agreement	8-K	10.01	12/26/17

10.10	Agreement by and between the Company and Hogier Gartner CIA S.A. dated February 16, 2018	8-K	10.1	2/23/18

10.11	2018 Professional/Consultant Stock Compensation Plan	S-8	10.1	1/18/18

10.12	Securities Purchase Agreement by and between the Company and Geneva Roth Remark Holdings, Inc., dated January 9, 2019	8-K	10.1	1/18/19

10.13	Equity Financing Agreement dated March 5, 2020 by and between SmartMetric, Inc. and GHS Investments LLC	S-1	10.13	8/6/20

10.14	Registration Rights Agreement by and between the Company and GHS Investments LLC, dated March 5, 2020	S-1	10.14	8/6/20

14.01	SmartMetric Code of Ethics	SB-2	16.1	9/3/04

21.01	Subsidiaries of the Registrant	S-B/A	21.1	2/3/05

31.1	Certification by the Principal Executive Officer of Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a))				X

31.2	Certification by the Principal Financial Officer of Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a))				X

32.1	Certification by the Principal Executive Officer pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002				X

32.2	Certification by the Principal Financial Officer pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002				X

101.INS	XBRL Instance Document				X

101.SCH	XBRL Taxonomy Extension Schema				X

101.CAL	XBRL Taxonomy Extension Calculation Linkbase				X

101.DEF	XBRL Taxonomy Extension Definition Linkbase				X

101.LAB	XBRL Taxonomy Extension Label Linkbase				X

101.PRE	XBRL Taxonomy Extension Presentation Linkbase				X

Management contracts or compensation plans or arrangements in which directors or executive officers are eligible to participate.

3840

Filing Compare · SmartMetric, Inc.